data_1b9u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1b9u _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.8 m -73.27 -32.05 64.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.676 0.79 . . . . 0.0 112.509 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -80.08 -48.59 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.815 0.846 . . . . 0.0 109.096 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -44.81 -56.89 4.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.848 2.059 . . . . 0.0 111.708 162.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.23 -31.53 79.42 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 121.779 -0.575 . . . . 0.0 113.95 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.29 -45.58 93.89 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.884 1.342 . . . . 0.0 111.027 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.38 73.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 mm -62.31 -51.32 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.304 0.956 . . . . 0.0 110.48 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.22 65.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.051 0.94 . . . . 0.0 111.222 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.88 -59.33 4.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.634 0.774 . . . . 0.0 112.666 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.89 -50.12 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.661 1.185 . . . . 0.0 111.293 -173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.4 mt -50.23 -47.31 55.04 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.494 0.588 . . . . 0.0 112.411 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -56.06 -58.51 7.62 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.907 0.883 . . . . 0.0 111.886 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -50.44 -55.18 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.624 1.17 . . . . 0.0 111.873 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.3 mt -68.35 -34.5 76.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.096 -1.003 . . . . 0.0 113.463 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -55.17 -41.63 72.12 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.648 0.658 . . . . 0.0 110.497 170.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 21.4 t -61.09 -41.14 96.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.821 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.7 mtp -67.59 -11.28 57.77 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.921 1.237 . . . . 0.0 114.298 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -127.76 -53.69 1.33 Allowed 'General case' 0 C--N 1.348 0.537 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -86.4 -2.35 58.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.85 -39.82 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.817 1.247 . . . . 0.0 111.472 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -49.54 -62.09 2.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.09 -54.74 4.74 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.017 3.145 . . . . 0.0 115.339 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 -37.18 26.06 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 121.913 1.719 . . . . 0.0 113.141 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.09 -50.52 66.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.888 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.2 ttm -58.32 -49.08 78.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.832 1.253 . . . . 0.0 111.401 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.94 90.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.277 1.031 . . . . 0.0 112.585 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.15 -51.27 68.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.75 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 123.669 0.788 . . . . 0.0 111.817 -177.565 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.4 m -72.96 -37.58 67.03 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.657 0.783 . . . . 0.0 112.084 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mm -78.17 -46.08 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.016 0.927 . . . . 0.0 109.162 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.7 tp -45.62 -55.56 6.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.562 1.945 . . . . 0.0 111.761 162.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.21 77.93 Favored Glycine 0 CA--C 1.543 1.801 0 O-C-N 121.684 -0.635 . . . . 0.0 113.997 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.64 -46.3 89.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.887 1.343 . . . . 0.0 111.227 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.27 73.62 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.34 -51.1 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.264 0.938 . . . . 0.0 110.489 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.27 -46.08 65.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.96 0.904 . . . . 0.0 111.052 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.91 -58.56 7.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.619 0.767 . . . . 0.0 112.789 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.74 -49.82 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.539 1.136 . . . . 0.0 111.458 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.0 mt -50.64 -46.64 58.41 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.428 0.558 . . . . 0.0 112.424 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -56.6 -59.29 5.22 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.771 0.828 . . . . 0.0 111.885 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.26 -46.63 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.809 1.243 . . . . 0.0 112.469 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.54 -34.42 58.53 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -54.11 -44.88 71.67 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.653 0.66 . . . . 0.0 109.935 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.16 -42.8 91.6 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.517 -0.739 . . . . 0.0 111.625 166.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.7 ttm -65.43 -19.95 66.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -132.83 -45.55 0.87 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -71.04 -27.0 63.34 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.272 0.629 . . . . 0.0 112.062 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.68 -48.16 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.181 1.392 . . . . 0.0 111.61 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -46.65 -63.07 1.49 Allowed Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 -54.94 4.08 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.6 2.867 . . . . 0.0 115.322 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.65 -36.65 32.09 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 121.83 1.689 . . . . 0.0 113.133 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.1 -51.56 63.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.699 0.799 . . . . 0.0 110.55 168.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.3 ttm -57.36 -48.2 79.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.681 1.193 . . . . 0.0 111.477 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.33 92.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.024 0.929 . . . . 0.0 112.505 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.69 -50.69 70.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.872 1.269 . . . . 0.0 112.951 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.104 . . . . 0.0 112.117 -176.361 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -72.77 -37.5 67.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.77 0.828 . . . . 0.0 111.822 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.32 -46.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.372 1.069 . . . . 0.0 108.805 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.46 -55.4 6.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.476 1.91 . . . . 0.0 111.8 162.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.13 78.84 Favored Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.724 -0.61 . . . . 0.0 114.17 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -59.71 -46.57 88.69 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.083 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.1 -32.37 73.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.9 mm -62.32 -50.97 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.24 0.927 . . . . 0.0 110.461 170.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.25 -46.13 65.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.972 0.909 . . . . 0.0 111.077 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.81 -58.64 7.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.657 0.783 . . . . 0.0 112.746 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.53 -49.88 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.609 1.164 . . . . 0.0 111.409 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -50.72 -46.07 58.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.445 0.566 . . . . 0.0 112.509 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -56.8 -59.73 4.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.75 0.82 . . . . 0.0 111.749 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -51.67 -45.96 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.802 1.241 . . . . 0.0 112.539 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.17 -33.06 56.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -57.04 -41.51 78.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.702 0.683 . . . . 0.0 110.281 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.57 -44.64 93.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.421 -0.8 . . . . 0.0 111.351 164.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 39.9 ttm -63.54 -17.18 62.54 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -130.99 -47.98 1.02 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.63 -23.23 60.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.856 0.862 . . . . 0.0 112.329 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.98 -46.27 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.263 1.425 . . . . 0.0 111.391 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -48.31 -63.62 1.47 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.56 -54.53 5.01 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.716 2.944 . . . . 0.0 115.394 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.77 -37.42 27.96 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 CA-C-N 121.901 1.714 . . . . 0.0 113.09 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.8 tt -53.49 -50.65 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.657 0.783 . . . . 0.0 110.635 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.3 ttt -58.04 -49.71 75.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.575 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.97 -37.74 77.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 0.0 112.974 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -56.24 9.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.988 1.315 . . . . 0.0 112.468 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 124.638 1.175 . . . . 0.0 111.553 -177.914 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -74.06 -29.96 62.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.19 0.996 . . . . 0.0 112.338 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.9 mm -81.25 -48.24 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.091 0.956 . . . . 0.0 108.951 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.62 -55.42 6.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.744 2.018 . . . . 0.0 111.277 164.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.67 74.16 Favored Glycine 0 CA--C 1.543 1.788 0 O-C-N 121.707 -0.62 . . . . 0.0 114.019 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -62.41 -44.21 96.99 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.095 1.447 . . . . 0.0 111.52 166.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.03 -32.56 73.96 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.474 -0.767 . . . . 0.0 112.795 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.16 -51.18 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.988 0.915 . . . . 0.0 110.546 170.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.16 -46.36 65.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.851 0.86 . . . . 0.0 111.114 175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -61.41 -58.41 8.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.762 0.825 . . . . 0.0 112.763 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.28 -50.11 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.521 1.128 . . . . 0.0 111.359 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.56 -46.4 57.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -56.55 -59.36 5.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.725 0.81 . . . . 0.0 111.87 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.4 -44.8 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.843 1.257 . . . . 0.0 112.662 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.14 -34.32 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.37 -44.06 71.89 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.667 0.667 . . . . 0.0 110.091 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -46.18 86.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.547 -0.721 . . . . 0.0 111.239 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.2 ttm -63.15 -19.62 64.64 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -133.82 -45.02 0.8 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -71.7 -26.76 62.63 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.698 -0.626 . . . . 0.0 112.171 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -108.7 -47.84 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.104 1.362 . . . . 0.0 111.572 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -46.93 -62.85 1.67 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.68 -54.3 5.08 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.631 2.887 . . . . 0.0 115.409 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.16 -36.34 29.4 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 121.899 1.714 . . . . 0.0 113.019 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.7 -48.62 74.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.858 0.754 . . . . 0.0 111.352 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.4 ttt -58.21 -49.15 78.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.808 1.243 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.06 -44.5 87.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.414 1.086 . . . . 0.0 112.301 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.8 70.21 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.155 1.382 . . . . 0.0 112.894 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 124.282 1.033 . . . . 0.0 111.478 -178.665 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.6 m -68.74 -33.72 74.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.191 0.596 . . . . 0.0 112.364 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.73 -47.27 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.114 0.966 . . . . 0.0 108.45 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.67 -56.09 5.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.621 1.968 . . . . 0.0 111.166 163.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.14 -31.06 74.21 Favored Glycine 0 CA--C 1.544 1.904 0 O-C-N 121.545 -0.722 . . . . 0.0 114.178 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -61.71 -44.3 97.19 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.897 1.349 . . . . 0.0 111.278 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.28 73.71 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.583 -0.698 . . . . 0.0 112.793 171.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.5 mm -62.34 -50.95 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.571 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.09 -46.37 65.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.903 0.881 . . . . 0.0 111.109 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -61.67 -58.55 7.62 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.709 0.804 . . . . 0.0 112.767 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.01 -49.84 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.523 1.129 . . . . 0.0 111.347 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.47 -46.69 57.01 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.4 -59.41 5.0 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.777 0.831 . . . . 0.0 111.786 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.39 -48.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.809 1.243 . . . . 0.0 112.317 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.53 -33.23 62.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -56.28 -43.79 79.15 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.679 0.672 . . . . 0.0 109.955 168.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.6 -38.97 86.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.764 -0.585 . . . . 0.0 111.919 166.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.1 ttm -64.74 -16.67 63.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.581 1.082 . . . . 0.0 113.634 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -126.76 -49.55 1.49 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -76.86 -18.57 58.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.895 0.878 . . . . 0.0 112.66 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.25 -43.16 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.728 1.211 . . . . 0.0 111.461 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -49.24 -62.11 2.75 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.59 -55.07 4.13 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.752 2.968 . . . . 0.0 115.414 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.94 -37.52 26.35 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.83 1.687 . . . . 0.0 112.931 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.7 tp -54.06 -50.16 67.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.719 0.691 . . . . 0.0 111.168 169.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.9 ttm -57.93 -49.65 76.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.736 1.214 . . . . 0.0 111.471 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.93 -46.86 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.304 1.042 . . . . 0.0 111.878 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.3 57.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.851 1.26 . . . . 0.0 112.996 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 125.219 1.408 . . . . 0.0 112.711 -175.71 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m -71.44 -37.99 71.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.156 0.983 . . . . 0.0 111.811 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.46 -46.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 108.84 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -45.15 -56.33 4.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.663 1.985 . . . . 0.0 111.823 161.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.05 -31.49 78.01 Favored Glycine 0 CA--C 1.545 1.908 0 O-C-N 121.629 -0.67 . . . . 0.0 114.188 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -60.36 -46.65 89.19 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.672 1.236 . . . . 0.0 110.978 166.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.07 73.28 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 172.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.8 mm -62.57 -51.54 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 119.255 0.934 . . . . 0.0 110.562 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.97 -45.25 64.35 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.048 0.939 . . . . 0.0 111.22 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.73 -59.51 4.8 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.676 0.79 . . . . 0.0 112.693 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.41 -48.87 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.668 1.187 . . . . 0.0 111.571 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.8 mt -50.67 -48.2 58.55 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.459 0.572 . . . . 0.0 112.315 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -56.13 -58.44 7.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.952 0.901 . . . . 0.0 111.931 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.1 -54.91 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.678 1.191 . . . . 0.0 111.79 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.4 mt -70.76 -32.39 69.52 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.83 -40.77 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.849 0.75 . . . . 0.0 110.434 167.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.6 t -61.05 -42.3 98.23 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.369 -0.832 . . . . 0.0 111.733 165.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.6 mtt -68.74 -11.47 60.33 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -133.0 -48.26 0.86 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -72.94 -23.02 60.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.917 0.887 . . . . 0.0 112.315 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.87 -46.02 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.289 1.436 . . . . 0.0 111.319 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -47.95 -63.4 1.52 Allowed Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.62 -54.76 4.59 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.764 2.976 . . . . 0.0 115.444 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.11 -35.96 31.36 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 CA-C-N 121.824 1.687 . . . . 0.0 113.164 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.94 -48.89 74.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.773 0.715 . . . . 0.0 111.265 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt -58.49 -46.96 85.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.802 1.241 . . . . 0.0 111.798 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.47 92.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.659 1.184 . . . . 0.0 112.466 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.41 -49.68 74.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.998 1.319 . . . . 0.0 112.724 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 124.465 1.106 . . . . 0.0 111.225 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.5 m -73.33 -30.5 63.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.337 0.655 . . . . 0.0 112.299 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.02 -53.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.286 1.034 . . . . 0.0 108.502 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -40.51 -56.71 2.0 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.371 2.268 . . . . 0.0 111.846 161.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.7 -30.21 77.31 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 123.32 0.486 . . . . 0.0 114.066 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -47.44 84.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.813 1.306 . . . . 0.0 111.036 167.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.24 72.31 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.73 -51.42 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.287 0.949 . . . . 0.0 110.566 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.2 -44.9 64.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.932 0.893 . . . . 0.0 111.221 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -63.09 -59.0 5.38 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.686 0.794 . . . . 0.0 112.704 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.42 -49.5 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.556 1.142 . . . . 0.0 111.458 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.95 -46.17 60.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.457 0.571 . . . . 0.0 112.446 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.01 -59.34 5.21 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.766 0.826 . . . . 0.0 111.793 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.07 -47.75 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.892 1.277 . . . . 0.0 112.329 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.46 -33.84 60.88 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.35 -42.03 77.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.65 0.659 . . . . 0.0 110.319 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.5 t -61.03 -40.88 95.28 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.554 -0.716 . . . . 0.0 111.628 165.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.7 ttm -65.98 -17.21 64.53 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.556 1.071 . . . . 0.0 113.87 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -129.73 -48.24 1.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.7 -23.21 60.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.992 0.917 . . . . 0.0 112.315 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.98 -45.16 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.335 1.454 . . . . 0.0 111.458 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -48.2 -62.58 2.09 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.71 -54.71 4.67 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.772 2.981 . . . . 0.0 115.33 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.18 -36.52 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 CA-C-N 121.852 1.697 . . . . 0.0 113.179 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.39 -50.66 67.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.988 0.915 . . . . 0.0 110.756 169.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -58.18 -48.34 80.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.733 1.213 . . . . 0.0 111.62 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.99 91.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.323 1.049 . . . . 0.0 112.587 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.32 68.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.926 1.291 . . . . 0.0 112.79 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt . . . . . 0 CA--C 1.543 0.68 0 C-N-CA 123.714 0.805 . . . . 0.0 111.779 -178.089 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.3 m -72.51 -32.47 66.19 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.39 0.676 . . . . 0.0 112.361 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.6 mm -79.52 -47.33 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.804 0.841 . . . . 0.0 109.054 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -46.17 -57.08 4.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.92 2.088 . . . . 0.0 111.25 163.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.03 -29.87 75.17 Favored Glycine 0 CA--C 1.544 1.878 0 O-C-N 121.682 -0.636 . . . . 0.0 114.05 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -62.97 -44.83 94.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.983 1.391 . . . . 0.0 111.132 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.23 73.02 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.584 -0.698 . . . . 0.0 112.801 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.3 mm -62.51 -51.29 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.146 0.885 . . . . 0.0 110.584 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.33 65.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 111.134 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -62.02 -58.86 6.25 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.868 0.867 . . . . 0.0 112.741 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.14 -49.53 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.518 1.127 . . . . 0.0 111.399 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.2 mt -50.58 -47.88 57.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.394 0.543 . . . . 0.0 112.358 172.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -55.64 -58.23 8.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.901 0.88 . . . . 0.0 111.994 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.6 -54.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.59 1.156 . . . . 0.0 111.826 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.48 -36.03 76.14 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.119 -0.988 . . . . 0.0 113.539 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -52.56 -44.28 65.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.693 0.679 . . . . 0.0 110.049 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.5 t -60.68 -40.38 91.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.917 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.7 mtp -73.3 -13.12 61.06 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.083 1.311 . . . . 0.0 114.463 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -139.74 -43.81 0.44 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.3 -28.51 64.17 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.738 -0.601 . . . . 0.0 111.864 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.98 -51.33 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.312 1.445 . . . . 0.0 111.566 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -45.98 -62.67 1.66 Allowed Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.12 -55.48 3.39 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.38 2.72 . . . . 0.0 115.316 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.02 -36.57 29.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.881 1.721 . . . . 0.0 113.092 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.9 tp -53.57 -50.33 65.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.388 0.675 . . . . 0.0 111.14 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -58.39 -48.24 81.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.282 1.033 . . . . 0.0 111.591 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.78 76.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.031 0.932 . . . . 0.0 111.742 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.27 -54.22 43.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 112.942 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 mm . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 125.281 1.433 . . . . 0.0 112.906 -176.148 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.3 m -69.01 -41.85 77.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.023 0.929 . . . . 0.0 112.989 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.55 -43.94 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.078 0.854 . . . . 0.0 109.132 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.0 tp -46.42 -55.38 7.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.266 1.826 . . . . 0.0 111.955 163.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -32.27 75.76 Favored Glycine 0 CA--C 1.542 1.778 0 O-C-N 121.637 -0.664 . . . . 0.0 114.067 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.01 -45.56 92.35 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.016 -1.285 . . . . 0.0 111.326 165.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.48 73.94 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.4 mm -62.09 -50.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.074 0.949 . . . . 0.0 110.483 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.23 65.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.916 0.887 . . . . 0.0 111.103 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.88 -58.42 8.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.661 0.784 . . . . 0.0 112.72 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.22 -50.2 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.528 1.131 . . . . 0.0 111.386 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.44 -46.22 56.41 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.71 -59.06 5.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.25 -45.87 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.585 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.91 -34.68 57.69 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.257 -0.902 . . . . 0.0 113.419 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -54.48 -44.25 72.47 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.635 0.652 . . . . 0.0 110.059 166.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -58.28 -45.83 87.16 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.579 -0.7 . . . . 0.0 111.256 165.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.7 ttp -63.5 -19.4 64.73 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -134.69 -45.28 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -71.26 -27.01 63.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.721 -0.612 . . . . 0.0 112.089 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.3 -48.42 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.073 1.349 . . . . 0.0 111.568 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -47.1 -63.0 1.58 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.7 -54.92 4.05 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.51 2.807 . . . . 0.0 115.32 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.55 -35.47 38.22 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 CA-C-N 121.873 1.704 . . . . 0.0 113.126 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.0 tp -55.92 -49.73 72.66 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.913 0.778 . . . . 0.0 111.278 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.2 ttm -58.46 -45.2 89.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.271 1.429 . . . . 0.0 111.911 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.7 85.05 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.475 1.11 . . . . 0.0 112.225 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.78 80.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.178 1.391 . . . . 0.0 112.74 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 124.465 1.106 . . . . 0.0 110.937 174.187 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.3 m -73.21 -32.43 64.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.224 0.61 . . . . 0.0 112.223 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.0 mt -77.42 -49.89 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.143 0.977 . . . . 0.0 108.648 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 tt -44.02 -58.0 3.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.431 2.292 . . . . 0.0 111.14 163.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.07 -30.11 76.29 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 121.619 -0.675 . . . . 0.0 114.067 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.56 -45.13 94.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.031 1.416 . . . . 0.0 110.826 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.12 -32.0 73.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.348 0.659 . . . . 0.0 112.702 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.49 -51.74 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.225 0.92 . . . . 0.0 110.59 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -44.56 64.4 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.038 0.935 . . . . 0.0 111.348 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.72 -59.21 4.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 112.685 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.25 -49.19 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.658 1.183 . . . . 0.0 111.469 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.44 -47.66 56.65 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.504 0.593 . . . . 0.0 112.377 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -56.39 -58.44 7.99 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.076 0.95 . . . . 0.0 111.91 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -50.34 -54.15 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.639 1.176 . . . . 0.0 111.767 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.18 -35.03 73.67 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.988 -1.07 . . . . 0.0 113.577 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.64 -42.8 68.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.669 0.668 . . . . 0.0 110.252 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 t -59.58 -45.69 91.14 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.473 -0.767 . . . . 0.0 111.362 166.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.9 mtp -69.38 -12.09 61.36 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.2 -40.04 0.44 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -173.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -75.45 -28.3 59.26 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.59 0.632 . . . . 0.0 111.627 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.77 -49.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.249 1.419 . . . . 0.0 111.316 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -46.79 -61.32 2.83 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.37 -54.84 4.0 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.319 2.68 . . . . 0.0 115.338 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.96 -37.5 26.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 121.922 1.722 . . . . 0.0 113.007 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.0 tp -54.35 -48.07 71.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.484 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.25 -50.48 73.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.547 1.139 . . . . 0.0 111.403 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.25 73.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 113.119 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.27 4.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.013 1.325 . . . . 0.0 112.156 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.3 mt . . . . . 0 CA--C 1.542 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 111.08 -178.499 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 121.027 0.441 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -77.05 63.24 2.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.784 1.234 . . . . 0.0 111.31 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.55 62.36 6.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.841 1.656 . . . . 0.0 109.194 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -26.75 -60.23 0.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.65 2.78 . . . . 0.0 114.167 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.75 -37.16 50.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.088 1.755 . . . . 0.0 113.677 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.8 m -73.27 -32.05 64.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.676 0.79 . . . . 0.0 112.509 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -80.08 -48.59 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.815 0.846 . . . . 0.0 109.096 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -44.81 -56.89 4.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.848 2.059 . . . . 0.0 111.708 162.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.23 -31.53 79.42 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 121.779 -0.575 . . . . 0.0 113.95 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.29 -45.58 93.89 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.884 1.342 . . . . 0.0 111.027 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.38 73.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 mm -62.31 -51.32 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.304 0.956 . . . . 0.0 110.48 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.22 65.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.051 0.94 . . . . 0.0 111.222 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.88 -59.33 4.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.634 0.774 . . . . 0.0 112.666 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.89 -50.12 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.661 1.185 . . . . 0.0 111.293 -173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.4 mt -50.23 -47.31 55.04 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.494 0.588 . . . . 0.0 112.411 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -56.06 -58.51 7.62 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.907 0.883 . . . . 0.0 111.886 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -50.44 -55.18 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.624 1.17 . . . . 0.0 111.873 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.3 mt -68.35 -34.5 76.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.096 -1.003 . . . . 0.0 113.463 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -55.17 -41.63 72.12 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.648 0.658 . . . . 0.0 110.497 170.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 21.4 t -61.09 -41.14 96.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.821 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.7 mtp -67.59 -11.28 57.77 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.921 1.237 . . . . 0.0 114.298 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -127.76 -53.69 1.33 Allowed 'General case' 0 C--N 1.348 0.537 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -86.4 -2.35 58.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.85 -39.82 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.817 1.247 . . . . 0.0 111.472 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -49.54 -62.09 2.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.09 -54.74 4.74 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.017 3.145 . . . . 0.0 115.339 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 -37.18 26.06 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 121.913 1.719 . . . . 0.0 113.141 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.09 -50.52 66.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.888 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.2 ttm -58.32 -49.08 78.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.832 1.253 . . . . 0.0 111.401 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.94 90.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.277 1.031 . . . . 0.0 112.585 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.15 -51.27 68.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.75 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.9 mt -77.63 -54.66 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.669 0.788 . . . . 0.0 111.817 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -73.67 64.87 0.94 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.874 1.27 . . . . 0.0 111.419 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.37 88.47 1.01 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.534 1.534 . . . . 0.0 108.496 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -35.76 -59.82 0.56 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.888 2.075 . . . . 0.0 113.336 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.26 -33.4 41.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.91 1.684 . . . . 0.0 113.523 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.4 m -72.96 -37.58 67.03 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.657 0.783 . . . . 0.0 112.084 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mm -78.17 -46.08 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.016 0.927 . . . . 0.0 109.162 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.7 tp -45.62 -55.56 6.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.562 1.945 . . . . 0.0 111.761 162.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.21 77.93 Favored Glycine 0 CA--C 1.543 1.801 0 O-C-N 121.684 -0.635 . . . . 0.0 113.997 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.64 -46.3 89.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.887 1.343 . . . . 0.0 111.227 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.27 73.62 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.34 -51.1 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.264 0.938 . . . . 0.0 110.489 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.27 -46.08 65.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.96 0.904 . . . . 0.0 111.052 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.91 -58.56 7.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.619 0.767 . . . . 0.0 112.789 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.74 -49.82 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.539 1.136 . . . . 0.0 111.458 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.0 mt -50.64 -46.64 58.41 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.428 0.558 . . . . 0.0 112.424 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -56.6 -59.29 5.22 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.771 0.828 . . . . 0.0 111.885 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.26 -46.63 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.809 1.243 . . . . 0.0 112.469 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.54 -34.42 58.53 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -54.11 -44.88 71.67 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.653 0.66 . . . . 0.0 109.935 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.16 -42.8 91.6 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.517 -0.739 . . . . 0.0 111.625 166.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.7 ttm -65.43 -19.95 66.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -132.83 -45.55 0.87 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -71.04 -27.0 63.34 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.272 0.629 . . . . 0.0 112.062 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.68 -48.16 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.181 1.392 . . . . 0.0 111.61 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -46.65 -63.07 1.49 Allowed Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 -54.94 4.08 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.6 2.867 . . . . 0.0 115.322 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.65 -36.65 32.09 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 121.83 1.689 . . . . 0.0 113.133 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.1 -51.56 63.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.699 0.799 . . . . 0.0 110.55 168.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.3 ttm -57.36 -48.2 79.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.681 1.193 . . . . 0.0 111.477 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.33 92.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.024 0.929 . . . . 0.0 112.505 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.69 -50.69 70.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.872 1.269 . . . . 0.0 112.951 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm -77.99 -52.52 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.104 . . . . 0.0 112.117 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.8 mtm . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 121.019 0.438 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.99 133.74 49.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.405 1.082 . . . . 0.0 111.568 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.44 53.46 1.55 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.613 1.165 . . . . 0.0 109.887 171.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -48.69 -54.28 15.45 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.174 1.79 . . . . 0.0 112.668 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.3 -33.63 20.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.016 1.726 . . . . 0.0 113.823 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -72.77 -37.5 67.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.77 0.828 . . . . 0.0 111.822 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.32 -46.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.372 1.069 . . . . 0.0 108.805 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.46 -55.4 6.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.476 1.91 . . . . 0.0 111.8 162.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.13 78.84 Favored Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.724 -0.61 . . . . 0.0 114.17 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -59.71 -46.57 88.69 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.083 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.1 -32.37 73.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.9 mm -62.32 -50.97 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.24 0.927 . . . . 0.0 110.461 170.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.25 -46.13 65.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.972 0.909 . . . . 0.0 111.077 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.81 -58.64 7.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.657 0.783 . . . . 0.0 112.746 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.53 -49.88 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.609 1.164 . . . . 0.0 111.409 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -50.72 -46.07 58.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.445 0.566 . . . . 0.0 112.509 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -56.8 -59.73 4.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.75 0.82 . . . . 0.0 111.749 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -51.67 -45.96 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.802 1.241 . . . . 0.0 112.539 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.17 -33.06 56.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -57.04 -41.51 78.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.702 0.683 . . . . 0.0 110.281 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.57 -44.64 93.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.421 -0.8 . . . . 0.0 111.351 164.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 39.9 ttm -63.54 -17.18 62.54 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -130.99 -47.98 1.02 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.63 -23.23 60.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.856 0.862 . . . . 0.0 112.329 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.98 -46.27 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.263 1.425 . . . . 0.0 111.391 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -48.31 -63.62 1.47 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.56 -54.53 5.01 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.716 2.944 . . . . 0.0 115.394 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.77 -37.42 27.96 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 CA-C-N 121.901 1.714 . . . . 0.0 113.09 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.8 tt -53.49 -50.65 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.657 0.783 . . . . 0.0 110.635 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.3 ttt -58.04 -49.71 75.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.575 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.97 -37.74 77.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 0.0 112.974 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -56.24 9.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.988 1.315 . . . . 0.0 112.468 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.01 -52.05 47.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.638 1.175 . . . . 0.0 111.553 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.216 0.532 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -81.0 55.54 2.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.923 1.289 . . . . 0.0 111.776 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.37 47.64 1.06 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.396 1.078 . . . . 0.0 110.984 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.09 -43.77 82.51 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.754 2.022 . . . . 0.0 112.196 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.68 25.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.468 1.507 . . . . 0.0 113.537 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -74.06 -29.96 62.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.19 0.996 . . . . 0.0 112.338 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.9 mm -81.25 -48.24 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.091 0.956 . . . . 0.0 108.951 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.62 -55.42 6.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.744 2.018 . . . . 0.0 111.277 164.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.67 74.16 Favored Glycine 0 CA--C 1.543 1.788 0 O-C-N 121.707 -0.62 . . . . 0.0 114.019 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -62.41 -44.21 96.99 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.095 1.447 . . . . 0.0 111.52 166.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.03 -32.56 73.96 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.474 -0.767 . . . . 0.0 112.795 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.16 -51.18 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.988 0.915 . . . . 0.0 110.546 170.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.16 -46.36 65.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.851 0.86 . . . . 0.0 111.114 175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -61.41 -58.41 8.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.762 0.825 . . . . 0.0 112.763 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.28 -50.11 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.521 1.128 . . . . 0.0 111.359 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.56 -46.4 57.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -56.55 -59.36 5.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.725 0.81 . . . . 0.0 111.87 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.4 -44.8 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.843 1.257 . . . . 0.0 112.662 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.14 -34.32 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.37 -44.06 71.89 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.667 0.667 . . . . 0.0 110.091 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -46.18 86.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.547 -0.721 . . . . 0.0 111.239 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.2 ttm -63.15 -19.62 64.64 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -133.82 -45.02 0.8 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -71.7 -26.76 62.63 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.698 -0.626 . . . . 0.0 112.171 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -108.7 -47.84 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.104 1.362 . . . . 0.0 111.572 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -46.93 -62.85 1.67 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.68 -54.3 5.08 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.631 2.887 . . . . 0.0 115.409 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.16 -36.34 29.4 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 121.899 1.714 . . . . 0.0 113.019 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.7 -48.62 74.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.858 0.754 . . . . 0.0 111.352 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.4 ttt -58.21 -49.15 78.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.808 1.243 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.06 -44.5 87.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.414 1.086 . . . . 0.0 112.301 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.8 70.21 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.155 1.382 . . . . 0.0 112.894 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.22 -55.61 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.282 1.033 . . . . 0.0 111.478 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 tpt . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -161.6 155.11 21.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.701 1.2 . . . . 0.0 110.523 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 tt -77.29 52.77 0.95 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.384 1.474 . . . . 0.0 111.252 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -167.06 -71.27 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 129.247 3.019 . . . . 0.0 107.179 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.71 70.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.804 1.641 . . . . 0.0 113.353 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.6 m -68.74 -33.72 74.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.191 0.596 . . . . 0.0 112.364 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.73 -47.27 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.114 0.966 . . . . 0.0 108.45 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.67 -56.09 5.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.621 1.968 . . . . 0.0 111.166 163.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.14 -31.06 74.21 Favored Glycine 0 CA--C 1.544 1.904 0 O-C-N 121.545 -0.722 . . . . 0.0 114.178 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -61.71 -44.3 97.19 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.897 1.349 . . . . 0.0 111.278 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.28 73.71 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.583 -0.698 . . . . 0.0 112.793 171.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.5 mm -62.34 -50.95 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.571 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.09 -46.37 65.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.903 0.881 . . . . 0.0 111.109 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -61.67 -58.55 7.62 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.709 0.804 . . . . 0.0 112.767 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.01 -49.84 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.523 1.129 . . . . 0.0 111.347 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.47 -46.69 57.01 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.4 -59.41 5.0 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.777 0.831 . . . . 0.0 111.786 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.39 -48.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.809 1.243 . . . . 0.0 112.317 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.53 -33.23 62.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -56.28 -43.79 79.15 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.679 0.672 . . . . 0.0 109.955 168.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.6 -38.97 86.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.764 -0.585 . . . . 0.0 111.919 166.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.1 ttm -64.74 -16.67 63.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.581 1.082 . . . . 0.0 113.634 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -126.76 -49.55 1.49 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -76.86 -18.57 58.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.895 0.878 . . . . 0.0 112.66 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.25 -43.16 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.728 1.211 . . . . 0.0 111.461 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -49.24 -62.11 2.75 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.59 -55.07 4.13 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.752 2.968 . . . . 0.0 115.414 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.94 -37.52 26.35 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.83 1.687 . . . . 0.0 112.931 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.7 tp -54.06 -50.16 67.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.719 0.691 . . . . 0.0 111.168 169.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.9 ttm -57.93 -49.65 76.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.736 1.214 . . . . 0.0 111.471 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.93 -46.86 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.304 1.042 . . . . 0.0 111.878 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.3 57.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.851 1.26 . . . . 0.0 112.996 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.0 mm -70.2 -44.56 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 125.219 1.408 . . . . 0.0 112.711 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mtp . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -76.63 63.94 2.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.826 1.25 . . . . 0.0 111.873 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.17 56.66 3.26 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.713 1.605 . . . . 0.0 110.187 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -31.8 -69.59 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.933 2.493 . . . . 0.0 113.778 -173.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.75 65.38 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.307 1.443 . . . . 0.0 113.883 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m -71.44 -37.99 71.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.156 0.983 . . . . 0.0 111.811 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.46 -46.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 108.84 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -45.15 -56.33 4.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.663 1.985 . . . . 0.0 111.823 161.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.05 -31.49 78.01 Favored Glycine 0 CA--C 1.545 1.908 0 O-C-N 121.629 -0.67 . . . . 0.0 114.188 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -60.36 -46.65 89.19 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.672 1.236 . . . . 0.0 110.978 166.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.07 73.28 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 172.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.8 mm -62.57 -51.54 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 119.255 0.934 . . . . 0.0 110.562 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.97 -45.25 64.35 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.048 0.939 . . . . 0.0 111.22 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.73 -59.51 4.8 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.676 0.79 . . . . 0.0 112.693 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.41 -48.87 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.668 1.187 . . . . 0.0 111.571 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.8 mt -50.67 -48.2 58.55 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.459 0.572 . . . . 0.0 112.315 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -56.13 -58.44 7.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.952 0.901 . . . . 0.0 111.931 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.1 -54.91 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.678 1.191 . . . . 0.0 111.79 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.4 mt -70.76 -32.39 69.52 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.83 -40.77 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.849 0.75 . . . . 0.0 110.434 167.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.6 t -61.05 -42.3 98.23 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.369 -0.832 . . . . 0.0 111.733 165.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.6 mtt -68.74 -11.47 60.33 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -133.0 -48.26 0.86 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -72.94 -23.02 60.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.917 0.887 . . . . 0.0 112.315 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.87 -46.02 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.289 1.436 . . . . 0.0 111.319 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -47.95 -63.4 1.52 Allowed Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.62 -54.76 4.59 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.764 2.976 . . . . 0.0 115.444 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.11 -35.96 31.36 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 CA-C-N 121.824 1.687 . . . . 0.0 113.164 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.94 -48.89 74.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.773 0.715 . . . . 0.0 111.265 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt -58.49 -46.96 85.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.802 1.241 . . . . 0.0 111.798 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.47 92.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.659 1.184 . . . . 0.0 112.466 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.41 -49.68 74.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.998 1.319 . . . . 0.0 112.724 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.0 -60.56 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.465 1.106 . . . . 0.0 111.225 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -77.33 62.06 2.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 111.453 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 tt -83.74 63.4 7.44 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.784 1.634 . . . . 0.0 108.974 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -22.68 -65.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.061 2.944 . . . . 0.0 114.136 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.69 -39.52 65.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.417 1.487 . . . . 0.0 113.622 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.5 m -73.33 -30.5 63.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.337 0.655 . . . . 0.0 112.299 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.02 -53.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.286 1.034 . . . . 0.0 108.502 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -40.51 -56.71 2.0 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.371 2.268 . . . . 0.0 111.846 161.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.7 -30.21 77.31 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 123.32 0.486 . . . . 0.0 114.066 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -47.44 84.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.813 1.306 . . . . 0.0 111.036 167.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.24 72.31 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.73 -51.42 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.287 0.949 . . . . 0.0 110.566 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.2 -44.9 64.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.932 0.893 . . . . 0.0 111.221 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -63.09 -59.0 5.38 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.686 0.794 . . . . 0.0 112.704 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.42 -49.5 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.556 1.142 . . . . 0.0 111.458 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.95 -46.17 60.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.457 0.571 . . . . 0.0 112.446 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.01 -59.34 5.21 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.766 0.826 . . . . 0.0 111.793 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.07 -47.75 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.892 1.277 . . . . 0.0 112.329 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.46 -33.84 60.88 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.35 -42.03 77.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.65 0.659 . . . . 0.0 110.319 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.5 t -61.03 -40.88 95.28 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.554 -0.716 . . . . 0.0 111.628 165.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.7 ttm -65.98 -17.21 64.53 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.556 1.071 . . . . 0.0 113.87 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -129.73 -48.24 1.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.7 -23.21 60.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.992 0.917 . . . . 0.0 112.315 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.98 -45.16 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.335 1.454 . . . . 0.0 111.458 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -48.2 -62.58 2.09 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.71 -54.71 4.67 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.772 2.981 . . . . 0.0 115.33 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.18 -36.52 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 CA-C-N 121.852 1.697 . . . . 0.0 113.179 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.39 -50.66 67.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.988 0.915 . . . . 0.0 110.756 169.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -58.18 -48.34 80.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.733 1.213 . . . . 0.0 111.62 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.99 91.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.323 1.049 . . . . 0.0 112.587 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.32 68.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.926 1.291 . . . . 0.0 112.79 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt -76.27 -55.66 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.714 0.805 . . . . 0.0 111.779 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -81.44 59.91 4.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.941 1.296 . . . . 0.0 111.445 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 tt -157.21 87.32 0.98 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.355 1.462 . . . . 0.0 108.637 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.29 -49.92 6.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.077 1.751 . . . . 0.0 113.173 -174.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.08 -34.4 60.05 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.994 1.318 . . . . 0.0 113.416 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.3 m -72.51 -32.47 66.19 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.39 0.676 . . . . 0.0 112.361 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.6 mm -79.52 -47.33 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.804 0.841 . . . . 0.0 109.054 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -46.17 -57.08 4.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.92 2.088 . . . . 0.0 111.25 163.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.03 -29.87 75.17 Favored Glycine 0 CA--C 1.544 1.878 0 O-C-N 121.682 -0.636 . . . . 0.0 114.05 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -62.97 -44.83 94.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.983 1.391 . . . . 0.0 111.132 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.23 73.02 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.584 -0.698 . . . . 0.0 112.801 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.3 mm -62.51 -51.29 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.146 0.885 . . . . 0.0 110.584 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.33 65.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 111.134 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -62.02 -58.86 6.25 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.868 0.867 . . . . 0.0 112.741 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.14 -49.53 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.518 1.127 . . . . 0.0 111.399 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.2 mt -50.58 -47.88 57.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.394 0.543 . . . . 0.0 112.358 172.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -55.64 -58.23 8.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.901 0.88 . . . . 0.0 111.994 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.6 -54.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.59 1.156 . . . . 0.0 111.826 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.48 -36.03 76.14 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.119 -0.988 . . . . 0.0 113.539 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -52.56 -44.28 65.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.693 0.679 . . . . 0.0 110.049 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.5 t -60.68 -40.38 91.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.917 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.7 mtp -73.3 -13.12 61.06 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.083 1.311 . . . . 0.0 114.463 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -139.74 -43.81 0.44 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.3 -28.51 64.17 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.738 -0.601 . . . . 0.0 111.864 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.98 -51.33 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.312 1.445 . . . . 0.0 111.566 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -45.98 -62.67 1.66 Allowed Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.12 -55.48 3.39 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.38 2.72 . . . . 0.0 115.316 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.02 -36.57 29.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.881 1.721 . . . . 0.0 113.092 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.9 tp -53.57 -50.33 65.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.388 0.675 . . . . 0.0 111.14 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -58.39 -48.24 81.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.282 1.033 . . . . 0.0 111.591 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.78 76.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.031 0.932 . . . . 0.0 111.742 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.27 -54.22 43.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 112.942 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 mm -68.77 -41.33 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.281 1.433 . . . . 0.0 112.906 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.167 0.508 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -162.28 152.3 16.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.38 1.472 . . . . 0.0 110.092 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -51.26 -51.65 52.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.122 1.369 . . . . 0.0 110.836 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -47.37 -61.76 1.75 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.818 1.247 . . . . 0.0 111.278 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.6 -36.25 55.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.702 1.601 . . . . 0.0 113.438 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.3 m -69.01 -41.85 77.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.023 0.929 . . . . 0.0 112.989 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.55 -43.94 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.078 0.854 . . . . 0.0 109.132 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.0 tp -46.42 -55.38 7.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.266 1.826 . . . . 0.0 111.955 163.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -32.27 75.76 Favored Glycine 0 CA--C 1.542 1.778 0 O-C-N 121.637 -0.664 . . . . 0.0 114.067 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.01 -45.56 92.35 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.016 -1.285 . . . . 0.0 111.326 165.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.48 73.94 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.4 mm -62.09 -50.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.074 0.949 . . . . 0.0 110.483 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.23 65.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.916 0.887 . . . . 0.0 111.103 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.88 -58.42 8.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.661 0.784 . . . . 0.0 112.72 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.22 -50.2 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.528 1.131 . . . . 0.0 111.386 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.44 -46.22 56.41 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.71 -59.06 5.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.25 -45.87 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.585 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.91 -34.68 57.69 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.257 -0.902 . . . . 0.0 113.419 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -54.48 -44.25 72.47 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.635 0.652 . . . . 0.0 110.059 166.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -58.28 -45.83 87.16 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.579 -0.7 . . . . 0.0 111.256 165.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.7 ttp -63.5 -19.4 64.73 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -134.69 -45.28 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -71.26 -27.01 63.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.721 -0.612 . . . . 0.0 112.089 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.3 -48.42 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.073 1.349 . . . . 0.0 111.568 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -47.1 -63.0 1.58 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.7 -54.92 4.05 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.51 2.807 . . . . 0.0 115.32 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.55 -35.47 38.22 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 CA-C-N 121.873 1.704 . . . . 0.0 113.126 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.0 tp -55.92 -49.73 72.66 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.913 0.778 . . . . 0.0 111.278 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.2 ttm -58.46 -45.2 89.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.271 1.429 . . . . 0.0 111.911 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.7 85.05 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.475 1.11 . . . . 0.0 112.225 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.78 80.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.178 1.391 . . . . 0.0 112.74 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.22 -49.15 82.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.465 1.106 . . . . 0.0 110.937 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -128.67 56.33 1.66 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.73 1.612 . . . . 0.0 109.476 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 tt -170.55 100.56 0.25 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.567 1.947 . . . . 0.0 106.967 -172.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -27.76 -64.47 0.09 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.583 2.353 . . . . 0.0 113.569 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.23 -35.39 64.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.085 1.354 . . . . 0.0 113.77 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.3 m -73.21 -32.43 64.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.224 0.61 . . . . 0.0 112.223 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.0 mt -77.42 -49.89 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.143 0.977 . . . . 0.0 108.648 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 tt -44.02 -58.0 3.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.431 2.292 . . . . 0.0 111.14 163.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.07 -30.11 76.29 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 121.619 -0.675 . . . . 0.0 114.067 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.56 -45.13 94.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.031 1.416 . . . . 0.0 110.826 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.12 -32.0 73.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.348 0.659 . . . . 0.0 112.702 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.49 -51.74 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.225 0.92 . . . . 0.0 110.59 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -44.56 64.4 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.038 0.935 . . . . 0.0 111.348 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.72 -59.21 4.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 112.685 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.25 -49.19 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.658 1.183 . . . . 0.0 111.469 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.44 -47.66 56.65 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.504 0.593 . . . . 0.0 112.377 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -56.39 -58.44 7.99 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.076 0.95 . . . . 0.0 111.91 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -50.34 -54.15 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.639 1.176 . . . . 0.0 111.767 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.18 -35.03 73.67 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.988 -1.07 . . . . 0.0 113.577 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.64 -42.8 68.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.669 0.668 . . . . 0.0 110.252 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 t -59.58 -45.69 91.14 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.473 -0.767 . . . . 0.0 111.362 166.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.9 mtp -69.38 -12.09 61.36 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.2 -40.04 0.44 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -173.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -75.45 -28.3 59.26 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.59 0.632 . . . . 0.0 111.627 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.77 -49.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.249 1.419 . . . . 0.0 111.316 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -46.79 -61.32 2.83 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.37 -54.84 4.0 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.319 2.68 . . . . 0.0 115.338 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.96 -37.5 26.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 121.922 1.722 . . . . 0.0 113.007 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.0 tp -54.35 -48.07 71.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.484 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.25 -50.48 73.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.547 1.139 . . . . 0.0 111.403 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.25 73.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 113.119 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.27 4.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.013 1.325 . . . . 0.0 112.156 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.25 -56.23 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 111.08 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.8 m -73.27 -32.05 64.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.676 0.79 . . . . 0.0 112.509 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -80.08 -48.59 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.815 0.846 . . . . 0.0 109.096 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -44.81 -56.89 4.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.848 2.059 . . . . 0.0 111.708 162.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.23 -31.53 79.42 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 121.779 -0.575 . . . . 0.0 113.95 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.29 -45.58 93.89 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.884 1.342 . . . . 0.0 111.027 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.38 73.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 mm -62.31 -51.32 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.304 0.956 . . . . 0.0 110.48 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.22 65.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.051 0.94 . . . . 0.0 111.222 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.88 -59.33 4.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.634 0.774 . . . . 0.0 112.666 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.89 -50.12 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.661 1.185 . . . . 0.0 111.293 -173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.4 mt -50.23 -47.31 55.04 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.494 0.588 . . . . 0.0 112.411 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -56.06 -58.51 7.62 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.907 0.883 . . . . 0.0 111.886 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -50.44 -55.18 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.624 1.17 . . . . 0.0 111.873 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.3 mt -68.35 -34.5 76.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.096 -1.003 . . . . 0.0 113.463 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -55.17 -41.63 72.12 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.648 0.658 . . . . 0.0 110.497 170.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 21.4 t -61.09 -41.14 96.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.821 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.7 mtp -67.59 -11.28 57.77 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.921 1.237 . . . . 0.0 114.298 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -127.76 -53.69 1.33 Allowed 'General case' 0 C--N 1.348 0.537 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -86.4 -2.35 58.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.85 -39.82 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.817 1.247 . . . . 0.0 111.472 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -49.54 -62.09 2.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.09 -54.74 4.74 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.017 3.145 . . . . 0.0 115.339 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 -37.18 26.06 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 121.913 1.719 . . . . 0.0 113.141 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.09 -50.52 66.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.888 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.2 ttm -58.32 -49.08 78.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.832 1.253 . . . . 0.0 111.401 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.94 90.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.277 1.031 . . . . 0.0 112.585 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.15 -51.27 68.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.75 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 123.669 0.788 . . . . 0.0 111.817 -177.565 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.4 m -72.96 -37.58 67.03 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.657 0.783 . . . . 0.0 112.084 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mm -78.17 -46.08 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.016 0.927 . . . . 0.0 109.162 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.7 tp -45.62 -55.56 6.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.562 1.945 . . . . 0.0 111.761 162.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.21 77.93 Favored Glycine 0 CA--C 1.543 1.801 0 O-C-N 121.684 -0.635 . . . . 0.0 113.997 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.64 -46.3 89.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.887 1.343 . . . . 0.0 111.227 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.27 73.62 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.34 -51.1 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.264 0.938 . . . . 0.0 110.489 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.27 -46.08 65.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.96 0.904 . . . . 0.0 111.052 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.91 -58.56 7.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.619 0.767 . . . . 0.0 112.789 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.74 -49.82 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.539 1.136 . . . . 0.0 111.458 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.0 mt -50.64 -46.64 58.41 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.428 0.558 . . . . 0.0 112.424 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -56.6 -59.29 5.22 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.771 0.828 . . . . 0.0 111.885 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.26 -46.63 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.809 1.243 . . . . 0.0 112.469 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.54 -34.42 58.53 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -54.11 -44.88 71.67 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.653 0.66 . . . . 0.0 109.935 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.16 -42.8 91.6 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.517 -0.739 . . . . 0.0 111.625 166.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.7 ttm -65.43 -19.95 66.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -132.83 -45.55 0.87 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -71.04 -27.0 63.34 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.272 0.629 . . . . 0.0 112.062 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.68 -48.16 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.181 1.392 . . . . 0.0 111.61 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -46.65 -63.07 1.49 Allowed Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 -54.94 4.08 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.6 2.867 . . . . 0.0 115.322 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.65 -36.65 32.09 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 121.83 1.689 . . . . 0.0 113.133 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.1 -51.56 63.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.699 0.799 . . . . 0.0 110.55 168.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.3 ttm -57.36 -48.2 79.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.681 1.193 . . . . 0.0 111.477 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.33 92.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.024 0.929 . . . . 0.0 112.505 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.69 -50.69 70.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.872 1.269 . . . . 0.0 112.951 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.104 . . . . 0.0 112.117 -176.361 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -72.77 -37.5 67.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.77 0.828 . . . . 0.0 111.822 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.32 -46.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.372 1.069 . . . . 0.0 108.805 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.46 -55.4 6.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.476 1.91 . . . . 0.0 111.8 162.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.13 78.84 Favored Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.724 -0.61 . . . . 0.0 114.17 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -59.71 -46.57 88.69 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.083 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.1 -32.37 73.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.9 mm -62.32 -50.97 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.24 0.927 . . . . 0.0 110.461 170.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.25 -46.13 65.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.972 0.909 . . . . 0.0 111.077 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.81 -58.64 7.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.657 0.783 . . . . 0.0 112.746 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.53 -49.88 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.609 1.164 . . . . 0.0 111.409 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -50.72 -46.07 58.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.445 0.566 . . . . 0.0 112.509 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -56.8 -59.73 4.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.75 0.82 . . . . 0.0 111.749 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -51.67 -45.96 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.802 1.241 . . . . 0.0 112.539 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.17 -33.06 56.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -57.04 -41.51 78.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.702 0.683 . . . . 0.0 110.281 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.57 -44.64 93.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.421 -0.8 . . . . 0.0 111.351 164.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 39.9 ttm -63.54 -17.18 62.54 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -130.99 -47.98 1.02 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.63 -23.23 60.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.856 0.862 . . . . 0.0 112.329 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.98 -46.27 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.263 1.425 . . . . 0.0 111.391 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -48.31 -63.62 1.47 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.56 -54.53 5.01 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.716 2.944 . . . . 0.0 115.394 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.77 -37.42 27.96 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 CA-C-N 121.901 1.714 . . . . 0.0 113.09 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.8 tt -53.49 -50.65 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.657 0.783 . . . . 0.0 110.635 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.3 ttt -58.04 -49.71 75.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.575 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.97 -37.74 77.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 0.0 112.974 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -56.24 9.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.988 1.315 . . . . 0.0 112.468 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 124.638 1.175 . . . . 0.0 111.553 -177.914 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -74.06 -29.96 62.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.19 0.996 . . . . 0.0 112.338 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.9 mm -81.25 -48.24 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.091 0.956 . . . . 0.0 108.951 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.62 -55.42 6.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.744 2.018 . . . . 0.0 111.277 164.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.67 74.16 Favored Glycine 0 CA--C 1.543 1.788 0 O-C-N 121.707 -0.62 . . . . 0.0 114.019 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -62.41 -44.21 96.99 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.095 1.447 . . . . 0.0 111.52 166.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.03 -32.56 73.96 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.474 -0.767 . . . . 0.0 112.795 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.16 -51.18 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.988 0.915 . . . . 0.0 110.546 170.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.16 -46.36 65.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.851 0.86 . . . . 0.0 111.114 175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -61.41 -58.41 8.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.762 0.825 . . . . 0.0 112.763 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.28 -50.11 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.521 1.128 . . . . 0.0 111.359 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.56 -46.4 57.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -56.55 -59.36 5.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.725 0.81 . . . . 0.0 111.87 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.4 -44.8 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.843 1.257 . . . . 0.0 112.662 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.14 -34.32 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.37 -44.06 71.89 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.667 0.667 . . . . 0.0 110.091 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -46.18 86.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.547 -0.721 . . . . 0.0 111.239 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.2 ttm -63.15 -19.62 64.64 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -133.82 -45.02 0.8 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -71.7 -26.76 62.63 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.698 -0.626 . . . . 0.0 112.171 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -108.7 -47.84 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.104 1.362 . . . . 0.0 111.572 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -46.93 -62.85 1.67 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.68 -54.3 5.08 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.631 2.887 . . . . 0.0 115.409 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.16 -36.34 29.4 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 121.899 1.714 . . . . 0.0 113.019 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.7 -48.62 74.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.858 0.754 . . . . 0.0 111.352 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.4 ttt -58.21 -49.15 78.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.808 1.243 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.06 -44.5 87.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.414 1.086 . . . . 0.0 112.301 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.8 70.21 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.155 1.382 . . . . 0.0 112.894 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 124.282 1.033 . . . . 0.0 111.478 -178.665 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.6 m -68.74 -33.72 74.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.191 0.596 . . . . 0.0 112.364 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.73 -47.27 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.114 0.966 . . . . 0.0 108.45 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.67 -56.09 5.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.621 1.968 . . . . 0.0 111.166 163.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.14 -31.06 74.21 Favored Glycine 0 CA--C 1.544 1.904 0 O-C-N 121.545 -0.722 . . . . 0.0 114.178 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -61.71 -44.3 97.19 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.897 1.349 . . . . 0.0 111.278 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.28 73.71 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.583 -0.698 . . . . 0.0 112.793 171.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.5 mm -62.34 -50.95 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.571 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.09 -46.37 65.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.903 0.881 . . . . 0.0 111.109 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -61.67 -58.55 7.62 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.709 0.804 . . . . 0.0 112.767 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.01 -49.84 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.523 1.129 . . . . 0.0 111.347 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.47 -46.69 57.01 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.4 -59.41 5.0 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.777 0.831 . . . . 0.0 111.786 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.39 -48.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.809 1.243 . . . . 0.0 112.317 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.53 -33.23 62.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -56.28 -43.79 79.15 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.679 0.672 . . . . 0.0 109.955 168.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.6 -38.97 86.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.764 -0.585 . . . . 0.0 111.919 166.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.1 ttm -64.74 -16.67 63.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.581 1.082 . . . . 0.0 113.634 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -126.76 -49.55 1.49 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -76.86 -18.57 58.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.895 0.878 . . . . 0.0 112.66 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.25 -43.16 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.728 1.211 . . . . 0.0 111.461 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -49.24 -62.11 2.75 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.59 -55.07 4.13 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.752 2.968 . . . . 0.0 115.414 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.94 -37.52 26.35 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.83 1.687 . . . . 0.0 112.931 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.7 tp -54.06 -50.16 67.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.719 0.691 . . . . 0.0 111.168 169.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.9 ttm -57.93 -49.65 76.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.736 1.214 . . . . 0.0 111.471 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.93 -46.86 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.304 1.042 . . . . 0.0 111.878 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.3 57.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.851 1.26 . . . . 0.0 112.996 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 125.219 1.408 . . . . 0.0 112.711 -175.71 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m -71.44 -37.99 71.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.156 0.983 . . . . 0.0 111.811 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.46 -46.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 108.84 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -45.15 -56.33 4.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.663 1.985 . . . . 0.0 111.823 161.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.05 -31.49 78.01 Favored Glycine 0 CA--C 1.545 1.908 0 O-C-N 121.629 -0.67 . . . . 0.0 114.188 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -60.36 -46.65 89.19 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.672 1.236 . . . . 0.0 110.978 166.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.07 73.28 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 172.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.8 mm -62.57 -51.54 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 119.255 0.934 . . . . 0.0 110.562 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.97 -45.25 64.35 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.048 0.939 . . . . 0.0 111.22 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.73 -59.51 4.8 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.676 0.79 . . . . 0.0 112.693 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.41 -48.87 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.668 1.187 . . . . 0.0 111.571 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.8 mt -50.67 -48.2 58.55 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.459 0.572 . . . . 0.0 112.315 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -56.13 -58.44 7.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.952 0.901 . . . . 0.0 111.931 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.1 -54.91 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.678 1.191 . . . . 0.0 111.79 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.4 mt -70.76 -32.39 69.52 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.83 -40.77 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.849 0.75 . . . . 0.0 110.434 167.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.6 t -61.05 -42.3 98.23 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.369 -0.832 . . . . 0.0 111.733 165.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.6 mtt -68.74 -11.47 60.33 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -133.0 -48.26 0.86 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -72.94 -23.02 60.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.917 0.887 . . . . 0.0 112.315 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.87 -46.02 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.289 1.436 . . . . 0.0 111.319 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -47.95 -63.4 1.52 Allowed Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.62 -54.76 4.59 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.764 2.976 . . . . 0.0 115.444 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.11 -35.96 31.36 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 CA-C-N 121.824 1.687 . . . . 0.0 113.164 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.94 -48.89 74.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.773 0.715 . . . . 0.0 111.265 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt -58.49 -46.96 85.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.802 1.241 . . . . 0.0 111.798 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.47 92.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.659 1.184 . . . . 0.0 112.466 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.41 -49.68 74.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.998 1.319 . . . . 0.0 112.724 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 124.465 1.106 . . . . 0.0 111.225 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.5 m -73.33 -30.5 63.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.337 0.655 . . . . 0.0 112.299 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.02 -53.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.286 1.034 . . . . 0.0 108.502 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -40.51 -56.71 2.0 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.371 2.268 . . . . 0.0 111.846 161.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.7 -30.21 77.31 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 123.32 0.486 . . . . 0.0 114.066 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -47.44 84.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.813 1.306 . . . . 0.0 111.036 167.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.24 72.31 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.73 -51.42 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.287 0.949 . . . . 0.0 110.566 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.2 -44.9 64.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.932 0.893 . . . . 0.0 111.221 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -63.09 -59.0 5.38 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.686 0.794 . . . . 0.0 112.704 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.42 -49.5 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.556 1.142 . . . . 0.0 111.458 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.95 -46.17 60.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.457 0.571 . . . . 0.0 112.446 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.01 -59.34 5.21 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.766 0.826 . . . . 0.0 111.793 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.07 -47.75 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.892 1.277 . . . . 0.0 112.329 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.46 -33.84 60.88 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.35 -42.03 77.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.65 0.659 . . . . 0.0 110.319 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.5 t -61.03 -40.88 95.28 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.554 -0.716 . . . . 0.0 111.628 165.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.7 ttm -65.98 -17.21 64.53 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.556 1.071 . . . . 0.0 113.87 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -129.73 -48.24 1.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.7 -23.21 60.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.992 0.917 . . . . 0.0 112.315 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.98 -45.16 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.335 1.454 . . . . 0.0 111.458 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -48.2 -62.58 2.09 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.71 -54.71 4.67 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.772 2.981 . . . . 0.0 115.33 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.18 -36.52 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 CA-C-N 121.852 1.697 . . . . 0.0 113.179 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.39 -50.66 67.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.988 0.915 . . . . 0.0 110.756 169.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -58.18 -48.34 80.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.733 1.213 . . . . 0.0 111.62 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.99 91.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.323 1.049 . . . . 0.0 112.587 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.32 68.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.926 1.291 . . . . 0.0 112.79 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt . . . . . 0 CA--C 1.543 0.68 0 C-N-CA 123.714 0.805 . . . . 0.0 111.779 -178.089 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.3 m -72.51 -32.47 66.19 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.39 0.676 . . . . 0.0 112.361 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.6 mm -79.52 -47.33 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.804 0.841 . . . . 0.0 109.054 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -46.17 -57.08 4.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.92 2.088 . . . . 0.0 111.25 163.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.03 -29.87 75.17 Favored Glycine 0 CA--C 1.544 1.878 0 O-C-N 121.682 -0.636 . . . . 0.0 114.05 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -62.97 -44.83 94.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.983 1.391 . . . . 0.0 111.132 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.23 73.02 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.584 -0.698 . . . . 0.0 112.801 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.3 mm -62.51 -51.29 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.146 0.885 . . . . 0.0 110.584 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.33 65.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 111.134 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -62.02 -58.86 6.25 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.868 0.867 . . . . 0.0 112.741 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.14 -49.53 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.518 1.127 . . . . 0.0 111.399 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.2 mt -50.58 -47.88 57.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.394 0.543 . . . . 0.0 112.358 172.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -55.64 -58.23 8.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.901 0.88 . . . . 0.0 111.994 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.6 -54.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.59 1.156 . . . . 0.0 111.826 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.48 -36.03 76.14 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.119 -0.988 . . . . 0.0 113.539 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -52.56 -44.28 65.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.693 0.679 . . . . 0.0 110.049 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.5 t -60.68 -40.38 91.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.917 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.7 mtp -73.3 -13.12 61.06 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.083 1.311 . . . . 0.0 114.463 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -139.74 -43.81 0.44 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.3 -28.51 64.17 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.738 -0.601 . . . . 0.0 111.864 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.98 -51.33 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.312 1.445 . . . . 0.0 111.566 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -45.98 -62.67 1.66 Allowed Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.12 -55.48 3.39 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.38 2.72 . . . . 0.0 115.316 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.02 -36.57 29.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.881 1.721 . . . . 0.0 113.092 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.9 tp -53.57 -50.33 65.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.388 0.675 . . . . 0.0 111.14 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -58.39 -48.24 81.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.282 1.033 . . . . 0.0 111.591 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.78 76.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.031 0.932 . . . . 0.0 111.742 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.27 -54.22 43.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 112.942 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 mm . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 125.281 1.433 . . . . 0.0 112.906 -176.148 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.3 m -69.01 -41.85 77.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.023 0.929 . . . . 0.0 112.989 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.55 -43.94 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.078 0.854 . . . . 0.0 109.132 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.0 tp -46.42 -55.38 7.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.266 1.826 . . . . 0.0 111.955 163.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -32.27 75.76 Favored Glycine 0 CA--C 1.542 1.778 0 O-C-N 121.637 -0.664 . . . . 0.0 114.067 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.01 -45.56 92.35 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.016 -1.285 . . . . 0.0 111.326 165.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.48 73.94 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.4 mm -62.09 -50.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.074 0.949 . . . . 0.0 110.483 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.23 65.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.916 0.887 . . . . 0.0 111.103 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.88 -58.42 8.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.661 0.784 . . . . 0.0 112.72 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.22 -50.2 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.528 1.131 . . . . 0.0 111.386 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.44 -46.22 56.41 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.71 -59.06 5.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.25 -45.87 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.585 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.91 -34.68 57.69 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.257 -0.902 . . . . 0.0 113.419 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -54.48 -44.25 72.47 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.635 0.652 . . . . 0.0 110.059 166.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -58.28 -45.83 87.16 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.579 -0.7 . . . . 0.0 111.256 165.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.7 ttp -63.5 -19.4 64.73 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -134.69 -45.28 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -71.26 -27.01 63.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.721 -0.612 . . . . 0.0 112.089 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.3 -48.42 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.073 1.349 . . . . 0.0 111.568 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -47.1 -63.0 1.58 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.7 -54.92 4.05 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.51 2.807 . . . . 0.0 115.32 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.55 -35.47 38.22 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 CA-C-N 121.873 1.704 . . . . 0.0 113.126 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.0 tp -55.92 -49.73 72.66 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.913 0.778 . . . . 0.0 111.278 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.2 ttm -58.46 -45.2 89.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.271 1.429 . . . . 0.0 111.911 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.7 85.05 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.475 1.11 . . . . 0.0 112.225 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.78 80.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.178 1.391 . . . . 0.0 112.74 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 124.465 1.106 . . . . 0.0 110.937 174.187 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.3 m -73.21 -32.43 64.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.224 0.61 . . . . 0.0 112.223 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.0 mt -77.42 -49.89 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.143 0.977 . . . . 0.0 108.648 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 tt -44.02 -58.0 3.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.431 2.292 . . . . 0.0 111.14 163.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.07 -30.11 76.29 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 121.619 -0.675 . . . . 0.0 114.067 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.56 -45.13 94.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.031 1.416 . . . . 0.0 110.826 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.12 -32.0 73.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.348 0.659 . . . . 0.0 112.702 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.49 -51.74 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.225 0.92 . . . . 0.0 110.59 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -44.56 64.4 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.038 0.935 . . . . 0.0 111.348 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.72 -59.21 4.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 112.685 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.25 -49.19 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.658 1.183 . . . . 0.0 111.469 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.44 -47.66 56.65 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.504 0.593 . . . . 0.0 112.377 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -56.39 -58.44 7.99 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.076 0.95 . . . . 0.0 111.91 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -50.34 -54.15 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.639 1.176 . . . . 0.0 111.767 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.18 -35.03 73.67 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.988 -1.07 . . . . 0.0 113.577 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.64 -42.8 68.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.669 0.668 . . . . 0.0 110.252 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 t -59.58 -45.69 91.14 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.473 -0.767 . . . . 0.0 111.362 166.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.9 mtp -69.38 -12.09 61.36 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.2 -40.04 0.44 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -173.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -75.45 -28.3 59.26 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.59 0.632 . . . . 0.0 111.627 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.77 -49.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.249 1.419 . . . . 0.0 111.316 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -46.79 -61.32 2.83 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.37 -54.84 4.0 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.319 2.68 . . . . 0.0 115.338 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.96 -37.5 26.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 121.922 1.722 . . . . 0.0 113.007 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.0 tp -54.35 -48.07 71.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.484 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.25 -50.48 73.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.547 1.139 . . . . 0.0 111.403 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.25 73.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 113.119 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.27 4.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.013 1.325 . . . . 0.0 112.156 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.3 mt . . . . . 0 CA--C 1.542 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 111.08 -178.499 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 121.027 0.441 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -77.05 63.24 2.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.784 1.234 . . . . 0.0 111.31 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.55 62.36 6.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.841 1.656 . . . . 0.0 109.194 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -26.75 -60.23 0.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.65 2.78 . . . . 0.0 114.167 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.75 -37.16 50.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.088 1.755 . . . . 0.0 113.677 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.8 m -73.27 -32.05 64.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.676 0.79 . . . . 0.0 112.509 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -80.08 -48.59 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.815 0.846 . . . . 0.0 109.096 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -44.81 -56.89 4.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.848 2.059 . . . . 0.0 111.708 162.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.23 -31.53 79.42 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 121.779 -0.575 . . . . 0.0 113.95 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.29 -45.58 93.89 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.884 1.342 . . . . 0.0 111.027 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.38 73.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 mm -62.31 -51.32 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.304 0.956 . . . . 0.0 110.48 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.22 65.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.051 0.94 . . . . 0.0 111.222 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.88 -59.33 4.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.634 0.774 . . . . 0.0 112.666 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.89 -50.12 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.661 1.185 . . . . 0.0 111.293 -173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.4 mt -50.23 -47.31 55.04 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.494 0.588 . . . . 0.0 112.411 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -56.06 -58.51 7.62 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.907 0.883 . . . . 0.0 111.886 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -50.44 -55.18 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.624 1.17 . . . . 0.0 111.873 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.3 mt -68.35 -34.5 76.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.096 -1.003 . . . . 0.0 113.463 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -55.17 -41.63 72.12 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.648 0.658 . . . . 0.0 110.497 170.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 21.4 t -61.09 -41.14 96.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.821 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.7 mtp -67.59 -11.28 57.77 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.921 1.237 . . . . 0.0 114.298 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -127.76 -53.69 1.33 Allowed 'General case' 0 C--N 1.348 0.537 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -86.4 -2.35 58.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.85 -39.82 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.817 1.247 . . . . 0.0 111.472 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -49.54 -62.09 2.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.09 -54.74 4.74 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.017 3.145 . . . . 0.0 115.339 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 -37.18 26.06 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 121.913 1.719 . . . . 0.0 113.141 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.09 -50.52 66.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.888 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.2 ttm -58.32 -49.08 78.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.832 1.253 . . . . 0.0 111.401 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.94 90.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.277 1.031 . . . . 0.0 112.585 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.15 -51.27 68.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.75 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.9 mt -77.63 -54.66 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.669 0.788 . . . . 0.0 111.817 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -73.67 64.87 0.94 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.874 1.27 . . . . 0.0 111.419 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.37 88.47 1.01 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.534 1.534 . . . . 0.0 108.496 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -35.76 -59.82 0.56 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.888 2.075 . . . . 0.0 113.336 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.26 -33.4 41.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.91 1.684 . . . . 0.0 113.523 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.4 m -72.96 -37.58 67.03 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.657 0.783 . . . . 0.0 112.084 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mm -78.17 -46.08 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.016 0.927 . . . . 0.0 109.162 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.7 tp -45.62 -55.56 6.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.562 1.945 . . . . 0.0 111.761 162.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.21 77.93 Favored Glycine 0 CA--C 1.543 1.801 0 O-C-N 121.684 -0.635 . . . . 0.0 113.997 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.64 -46.3 89.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.887 1.343 . . . . 0.0 111.227 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.27 73.62 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.34 -51.1 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.264 0.938 . . . . 0.0 110.489 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.27 -46.08 65.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.96 0.904 . . . . 0.0 111.052 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.91 -58.56 7.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.619 0.767 . . . . 0.0 112.789 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.74 -49.82 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.539 1.136 . . . . 0.0 111.458 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.0 mt -50.64 -46.64 58.41 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.428 0.558 . . . . 0.0 112.424 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -56.6 -59.29 5.22 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.771 0.828 . . . . 0.0 111.885 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.26 -46.63 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.809 1.243 . . . . 0.0 112.469 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.54 -34.42 58.53 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -54.11 -44.88 71.67 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.653 0.66 . . . . 0.0 109.935 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.16 -42.8 91.6 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.517 -0.739 . . . . 0.0 111.625 166.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.7 ttm -65.43 -19.95 66.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -132.83 -45.55 0.87 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -71.04 -27.0 63.34 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.272 0.629 . . . . 0.0 112.062 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.68 -48.16 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.181 1.392 . . . . 0.0 111.61 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -46.65 -63.07 1.49 Allowed Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 -54.94 4.08 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.6 2.867 . . . . 0.0 115.322 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.65 -36.65 32.09 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 121.83 1.689 . . . . 0.0 113.133 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.1 -51.56 63.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.699 0.799 . . . . 0.0 110.55 168.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.3 ttm -57.36 -48.2 79.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.681 1.193 . . . . 0.0 111.477 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.33 92.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.024 0.929 . . . . 0.0 112.505 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.69 -50.69 70.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.872 1.269 . . . . 0.0 112.951 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm -77.99 -52.52 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.104 . . . . 0.0 112.117 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.8 mtm . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 121.019 0.438 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.99 133.74 49.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.405 1.082 . . . . 0.0 111.568 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.44 53.46 1.55 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.613 1.165 . . . . 0.0 109.887 171.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -48.69 -54.28 15.45 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.174 1.79 . . . . 0.0 112.668 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.3 -33.63 20.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.016 1.726 . . . . 0.0 113.823 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -72.77 -37.5 67.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.77 0.828 . . . . 0.0 111.822 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.32 -46.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.372 1.069 . . . . 0.0 108.805 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.46 -55.4 6.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.476 1.91 . . . . 0.0 111.8 162.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.13 78.84 Favored Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.724 -0.61 . . . . 0.0 114.17 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -59.71 -46.57 88.69 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.083 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.1 -32.37 73.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.9 mm -62.32 -50.97 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.24 0.927 . . . . 0.0 110.461 170.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.25 -46.13 65.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.972 0.909 . . . . 0.0 111.077 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.81 -58.64 7.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.657 0.783 . . . . 0.0 112.746 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.53 -49.88 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.609 1.164 . . . . 0.0 111.409 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -50.72 -46.07 58.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.445 0.566 . . . . 0.0 112.509 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -56.8 -59.73 4.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.75 0.82 . . . . 0.0 111.749 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -51.67 -45.96 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.802 1.241 . . . . 0.0 112.539 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.17 -33.06 56.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -57.04 -41.51 78.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.702 0.683 . . . . 0.0 110.281 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.57 -44.64 93.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.421 -0.8 . . . . 0.0 111.351 164.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 39.9 ttm -63.54 -17.18 62.54 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -130.99 -47.98 1.02 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.63 -23.23 60.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.856 0.862 . . . . 0.0 112.329 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.98 -46.27 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.263 1.425 . . . . 0.0 111.391 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -48.31 -63.62 1.47 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.56 -54.53 5.01 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.716 2.944 . . . . 0.0 115.394 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.77 -37.42 27.96 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 CA-C-N 121.901 1.714 . . . . 0.0 113.09 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.8 tt -53.49 -50.65 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.657 0.783 . . . . 0.0 110.635 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.3 ttt -58.04 -49.71 75.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.575 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.97 -37.74 77.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 0.0 112.974 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -56.24 9.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.988 1.315 . . . . 0.0 112.468 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.01 -52.05 47.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.638 1.175 . . . . 0.0 111.553 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.216 0.532 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -81.0 55.54 2.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.923 1.289 . . . . 0.0 111.776 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.37 47.64 1.06 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.396 1.078 . . . . 0.0 110.984 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.09 -43.77 82.51 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.754 2.022 . . . . 0.0 112.196 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.68 25.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.468 1.507 . . . . 0.0 113.537 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -74.06 -29.96 62.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.19 0.996 . . . . 0.0 112.338 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.9 mm -81.25 -48.24 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.091 0.956 . . . . 0.0 108.951 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.62 -55.42 6.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.744 2.018 . . . . 0.0 111.277 164.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.67 74.16 Favored Glycine 0 CA--C 1.543 1.788 0 O-C-N 121.707 -0.62 . . . . 0.0 114.019 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -62.41 -44.21 96.99 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.095 1.447 . . . . 0.0 111.52 166.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.03 -32.56 73.96 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.474 -0.767 . . . . 0.0 112.795 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.16 -51.18 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.988 0.915 . . . . 0.0 110.546 170.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.16 -46.36 65.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.851 0.86 . . . . 0.0 111.114 175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -61.41 -58.41 8.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.762 0.825 . . . . 0.0 112.763 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.28 -50.11 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.521 1.128 . . . . 0.0 111.359 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.56 -46.4 57.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -56.55 -59.36 5.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.725 0.81 . . . . 0.0 111.87 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.4 -44.8 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.843 1.257 . . . . 0.0 112.662 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.14 -34.32 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.37 -44.06 71.89 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.667 0.667 . . . . 0.0 110.091 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -46.18 86.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.547 -0.721 . . . . 0.0 111.239 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.2 ttm -63.15 -19.62 64.64 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -133.82 -45.02 0.8 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -71.7 -26.76 62.63 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.698 -0.626 . . . . 0.0 112.171 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -108.7 -47.84 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.104 1.362 . . . . 0.0 111.572 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -46.93 -62.85 1.67 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.68 -54.3 5.08 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.631 2.887 . . . . 0.0 115.409 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.16 -36.34 29.4 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 121.899 1.714 . . . . 0.0 113.019 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.7 -48.62 74.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.858 0.754 . . . . 0.0 111.352 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.4 ttt -58.21 -49.15 78.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.808 1.243 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.06 -44.5 87.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.414 1.086 . . . . 0.0 112.301 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.8 70.21 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.155 1.382 . . . . 0.0 112.894 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.22 -55.61 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.282 1.033 . . . . 0.0 111.478 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 tpt . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -161.6 155.11 21.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.701 1.2 . . . . 0.0 110.523 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 tt -77.29 52.77 0.95 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.384 1.474 . . . . 0.0 111.252 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -167.06 -71.27 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 129.247 3.019 . . . . 0.0 107.179 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.71 70.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.804 1.641 . . . . 0.0 113.353 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.6 m -68.74 -33.72 74.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.191 0.596 . . . . 0.0 112.364 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.73 -47.27 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.114 0.966 . . . . 0.0 108.45 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.67 -56.09 5.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.621 1.968 . . . . 0.0 111.166 163.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.14 -31.06 74.21 Favored Glycine 0 CA--C 1.544 1.904 0 O-C-N 121.545 -0.722 . . . . 0.0 114.178 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -61.71 -44.3 97.19 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.897 1.349 . . . . 0.0 111.278 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.28 73.71 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.583 -0.698 . . . . 0.0 112.793 171.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.5 mm -62.34 -50.95 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.571 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.09 -46.37 65.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.903 0.881 . . . . 0.0 111.109 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -61.67 -58.55 7.62 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.709 0.804 . . . . 0.0 112.767 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.01 -49.84 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.523 1.129 . . . . 0.0 111.347 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.47 -46.69 57.01 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.4 -59.41 5.0 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.777 0.831 . . . . 0.0 111.786 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.39 -48.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.809 1.243 . . . . 0.0 112.317 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.53 -33.23 62.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -56.28 -43.79 79.15 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.679 0.672 . . . . 0.0 109.955 168.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.6 -38.97 86.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.764 -0.585 . . . . 0.0 111.919 166.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.1 ttm -64.74 -16.67 63.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.581 1.082 . . . . 0.0 113.634 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -126.76 -49.55 1.49 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -76.86 -18.57 58.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.895 0.878 . . . . 0.0 112.66 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.25 -43.16 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.728 1.211 . . . . 0.0 111.461 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -49.24 -62.11 2.75 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.59 -55.07 4.13 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.752 2.968 . . . . 0.0 115.414 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.94 -37.52 26.35 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.83 1.687 . . . . 0.0 112.931 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.7 tp -54.06 -50.16 67.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.719 0.691 . . . . 0.0 111.168 169.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.9 ttm -57.93 -49.65 76.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.736 1.214 . . . . 0.0 111.471 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.93 -46.86 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.304 1.042 . . . . 0.0 111.878 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.3 57.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.851 1.26 . . . . 0.0 112.996 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.0 mm -70.2 -44.56 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 125.219 1.408 . . . . 0.0 112.711 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mtp . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -76.63 63.94 2.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.826 1.25 . . . . 0.0 111.873 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.17 56.66 3.26 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.713 1.605 . . . . 0.0 110.187 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -31.8 -69.59 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.933 2.493 . . . . 0.0 113.778 -173.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.75 65.38 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.307 1.443 . . . . 0.0 113.883 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m -71.44 -37.99 71.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.156 0.983 . . . . 0.0 111.811 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.46 -46.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 108.84 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -45.15 -56.33 4.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.663 1.985 . . . . 0.0 111.823 161.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.05 -31.49 78.01 Favored Glycine 0 CA--C 1.545 1.908 0 O-C-N 121.629 -0.67 . . . . 0.0 114.188 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -60.36 -46.65 89.19 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.672 1.236 . . . . 0.0 110.978 166.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.07 73.28 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 172.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.8 mm -62.57 -51.54 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 119.255 0.934 . . . . 0.0 110.562 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.97 -45.25 64.35 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.048 0.939 . . . . 0.0 111.22 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.73 -59.51 4.8 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.676 0.79 . . . . 0.0 112.693 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.41 -48.87 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.668 1.187 . . . . 0.0 111.571 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.8 mt -50.67 -48.2 58.55 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.459 0.572 . . . . 0.0 112.315 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -56.13 -58.44 7.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.952 0.901 . . . . 0.0 111.931 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.1 -54.91 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.678 1.191 . . . . 0.0 111.79 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.4 mt -70.76 -32.39 69.52 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.83 -40.77 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.849 0.75 . . . . 0.0 110.434 167.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.6 t -61.05 -42.3 98.23 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.369 -0.832 . . . . 0.0 111.733 165.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.6 mtt -68.74 -11.47 60.33 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -133.0 -48.26 0.86 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -72.94 -23.02 60.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.917 0.887 . . . . 0.0 112.315 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.87 -46.02 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.289 1.436 . . . . 0.0 111.319 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -47.95 -63.4 1.52 Allowed Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.62 -54.76 4.59 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.764 2.976 . . . . 0.0 115.444 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.11 -35.96 31.36 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 CA-C-N 121.824 1.687 . . . . 0.0 113.164 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.94 -48.89 74.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.773 0.715 . . . . 0.0 111.265 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt -58.49 -46.96 85.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.802 1.241 . . . . 0.0 111.798 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.47 92.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.659 1.184 . . . . 0.0 112.466 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.41 -49.68 74.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.998 1.319 . . . . 0.0 112.724 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.0 -60.56 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.465 1.106 . . . . 0.0 111.225 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -77.33 62.06 2.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 111.453 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 tt -83.74 63.4 7.44 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.784 1.634 . . . . 0.0 108.974 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -22.68 -65.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.061 2.944 . . . . 0.0 114.136 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.69 -39.52 65.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.417 1.487 . . . . 0.0 113.622 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.5 m -73.33 -30.5 63.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.337 0.655 . . . . 0.0 112.299 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.02 -53.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.286 1.034 . . . . 0.0 108.502 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -40.51 -56.71 2.0 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.371 2.268 . . . . 0.0 111.846 161.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.7 -30.21 77.31 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 123.32 0.486 . . . . 0.0 114.066 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -47.44 84.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.813 1.306 . . . . 0.0 111.036 167.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.24 72.31 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.73 -51.42 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.287 0.949 . . . . 0.0 110.566 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.2 -44.9 64.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.932 0.893 . . . . 0.0 111.221 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -63.09 -59.0 5.38 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.686 0.794 . . . . 0.0 112.704 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.42 -49.5 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.556 1.142 . . . . 0.0 111.458 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.95 -46.17 60.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.457 0.571 . . . . 0.0 112.446 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.01 -59.34 5.21 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.766 0.826 . . . . 0.0 111.793 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.07 -47.75 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.892 1.277 . . . . 0.0 112.329 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.46 -33.84 60.88 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.35 -42.03 77.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.65 0.659 . . . . 0.0 110.319 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.5 t -61.03 -40.88 95.28 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.554 -0.716 . . . . 0.0 111.628 165.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.7 ttm -65.98 -17.21 64.53 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.556 1.071 . . . . 0.0 113.87 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -129.73 -48.24 1.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.7 -23.21 60.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.992 0.917 . . . . 0.0 112.315 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.98 -45.16 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.335 1.454 . . . . 0.0 111.458 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -48.2 -62.58 2.09 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.71 -54.71 4.67 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.772 2.981 . . . . 0.0 115.33 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.18 -36.52 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 CA-C-N 121.852 1.697 . . . . 0.0 113.179 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.39 -50.66 67.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.988 0.915 . . . . 0.0 110.756 169.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -58.18 -48.34 80.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.733 1.213 . . . . 0.0 111.62 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.99 91.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.323 1.049 . . . . 0.0 112.587 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.32 68.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.926 1.291 . . . . 0.0 112.79 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt -76.27 -55.66 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.714 0.805 . . . . 0.0 111.779 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -81.44 59.91 4.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.941 1.296 . . . . 0.0 111.445 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 tt -157.21 87.32 0.98 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.355 1.462 . . . . 0.0 108.637 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -43.29 -49.92 6.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.077 1.751 . . . . 0.0 113.173 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.08 -34.4 60.05 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.994 1.318 . . . . 0.0 113.416 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.3 m -72.51 -32.47 66.19 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.39 0.676 . . . . 0.0 112.361 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.6 mm -79.52 -47.33 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.804 0.841 . . . . 0.0 109.054 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -46.17 -57.08 4.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.92 2.088 . . . . 0.0 111.25 163.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.03 -29.87 75.17 Favored Glycine 0 CA--C 1.544 1.878 0 O-C-N 121.682 -0.636 . . . . 0.0 114.05 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -62.97 -44.83 94.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.983 1.391 . . . . 0.0 111.132 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.23 73.02 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.584 -0.698 . . . . 0.0 112.801 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.3 mm -62.51 -51.29 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.146 0.885 . . . . 0.0 110.584 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.33 65.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 111.134 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -62.02 -58.86 6.25 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.868 0.867 . . . . 0.0 112.741 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.14 -49.53 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.518 1.127 . . . . 0.0 111.399 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.2 mt -50.58 -47.88 57.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.394 0.543 . . . . 0.0 112.358 172.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -55.64 -58.23 8.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.901 0.88 . . . . 0.0 111.994 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.6 -54.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.59 1.156 . . . . 0.0 111.826 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.48 -36.03 76.14 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.119 -0.988 . . . . 0.0 113.539 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -52.56 -44.28 65.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.693 0.679 . . . . 0.0 110.049 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.5 t -60.68 -40.38 91.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.917 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.7 mtp -73.3 -13.12 61.06 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.083 1.311 . . . . 0.0 114.463 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -139.74 -43.81 0.44 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.3 -28.51 64.17 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.738 -0.601 . . . . 0.0 111.864 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.98 -51.33 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.312 1.445 . . . . 0.0 111.566 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -45.98 -62.67 1.66 Allowed Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.12 -55.48 3.39 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.38 2.72 . . . . 0.0 115.316 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.02 -36.57 29.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.881 1.721 . . . . 0.0 113.092 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.9 tp -53.57 -50.33 65.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.388 0.675 . . . . 0.0 111.14 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -58.39 -48.24 81.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.282 1.033 . . . . 0.0 111.591 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.78 76.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.031 0.932 . . . . 0.0 111.742 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.27 -54.22 43.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 112.942 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 mm -68.77 -41.33 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.281 1.433 . . . . 0.0 112.906 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.167 0.508 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -162.28 152.3 16.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.38 1.472 . . . . 0.0 110.092 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -51.26 -51.65 52.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.122 1.369 . . . . 0.0 110.836 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -47.37 -61.76 1.75 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.818 1.247 . . . . 0.0 111.278 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.6 -36.25 55.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.702 1.601 . . . . 0.0 113.438 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.3 m -69.01 -41.85 77.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.023 0.929 . . . . 0.0 112.989 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.55 -43.94 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.078 0.854 . . . . 0.0 109.132 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.0 tp -46.42 -55.38 7.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.266 1.826 . . . . 0.0 111.955 163.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -32.27 75.76 Favored Glycine 0 CA--C 1.542 1.778 0 O-C-N 121.637 -0.664 . . . . 0.0 114.067 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.01 -45.56 92.35 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.016 -1.285 . . . . 0.0 111.326 165.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.48 73.94 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.4 mm -62.09 -50.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.074 0.949 . . . . 0.0 110.483 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.23 65.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.916 0.887 . . . . 0.0 111.103 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.88 -58.42 8.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.661 0.784 . . . . 0.0 112.72 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.22 -50.2 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.528 1.131 . . . . 0.0 111.386 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.44 -46.22 56.41 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.71 -59.06 5.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.25 -45.87 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.585 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.91 -34.68 57.69 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.257 -0.902 . . . . 0.0 113.419 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -54.48 -44.25 72.47 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.635 0.652 . . . . 0.0 110.059 166.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -58.28 -45.83 87.16 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.579 -0.7 . . . . 0.0 111.256 165.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.7 ttp -63.5 -19.4 64.73 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -134.69 -45.28 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -71.26 -27.01 63.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.721 -0.612 . . . . 0.0 112.089 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.3 -48.42 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.073 1.349 . . . . 0.0 111.568 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -47.1 -63.0 1.58 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.7 -54.92 4.05 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.51 2.807 . . . . 0.0 115.32 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.55 -35.47 38.22 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 CA-C-N 121.873 1.704 . . . . 0.0 113.126 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.0 tp -55.92 -49.73 72.66 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.913 0.778 . . . . 0.0 111.278 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.2 ttm -58.46 -45.2 89.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.271 1.429 . . . . 0.0 111.911 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.7 85.05 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.475 1.11 . . . . 0.0 112.225 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.78 80.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.178 1.391 . . . . 0.0 112.74 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.22 -49.15 82.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.465 1.106 . . . . 0.0 110.937 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -128.67 56.33 1.66 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.73 1.612 . . . . 0.0 109.476 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 tt -170.55 100.56 0.25 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.567 1.947 . . . . 0.0 106.967 -172.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -27.76 -64.47 0.09 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.583 2.353 . . . . 0.0 113.569 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.23 -35.39 64.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.085 1.354 . . . . 0.0 113.77 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.3 m -73.21 -32.43 64.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.224 0.61 . . . . 0.0 112.223 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.0 mt -77.42 -49.89 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.143 0.977 . . . . 0.0 108.648 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 tt -44.02 -58.0 3.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.431 2.292 . . . . 0.0 111.14 163.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.07 -30.11 76.29 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 121.619 -0.675 . . . . 0.0 114.067 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.56 -45.13 94.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.031 1.416 . . . . 0.0 110.826 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.12 -32.0 73.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.348 0.659 . . . . 0.0 112.702 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.49 -51.74 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.225 0.92 . . . . 0.0 110.59 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -44.56 64.4 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.038 0.935 . . . . 0.0 111.348 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.72 -59.21 4.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 112.685 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.25 -49.19 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.658 1.183 . . . . 0.0 111.469 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.44 -47.66 56.65 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.504 0.593 . . . . 0.0 112.377 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -56.39 -58.44 7.99 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.076 0.95 . . . . 0.0 111.91 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -50.34 -54.15 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.639 1.176 . . . . 0.0 111.767 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.18 -35.03 73.67 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.988 -1.07 . . . . 0.0 113.577 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.64 -42.8 68.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.669 0.668 . . . . 0.0 110.252 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 t -59.58 -45.69 91.14 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.473 -0.767 . . . . 0.0 111.362 166.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.9 mtp -69.38 -12.09 61.36 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.2 -40.04 0.44 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -173.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -75.45 -28.3 59.26 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.59 0.632 . . . . 0.0 111.627 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.77 -49.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.249 1.419 . . . . 0.0 111.316 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -46.79 -61.32 2.83 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.37 -54.84 4.0 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.319 2.68 . . . . 0.0 115.338 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.96 -37.5 26.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 121.922 1.722 . . . . 0.0 113.007 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.0 tp -54.35 -48.07 71.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.484 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.25 -50.48 73.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.547 1.139 . . . . 0.0 111.403 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.25 73.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 113.119 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.27 4.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.013 1.325 . . . . 0.0 112.156 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.25 -56.23 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 111.08 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.8 m -73.27 -32.05 64.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.676 0.79 . . . . 0.0 112.509 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -80.08 -48.59 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.815 0.846 . . . . 0.0 109.096 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -44.81 -56.89 4.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.848 2.059 . . . . 0.0 111.708 162.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.23 -31.53 79.42 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 121.779 -0.575 . . . . 0.0 113.95 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.29 -45.58 93.89 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.884 1.342 . . . . 0.0 111.027 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.38 73.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 mm -62.31 -51.32 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.304 0.956 . . . . 0.0 110.48 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.22 65.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.051 0.94 . . . . 0.0 111.222 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.88 -59.33 4.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.634 0.774 . . . . 0.0 112.666 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.89 -50.12 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.661 1.185 . . . . 0.0 111.293 -173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.4 mt -50.23 -47.31 55.04 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.494 0.588 . . . . 0.0 112.411 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -56.06 -58.51 7.62 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.907 0.883 . . . . 0.0 111.886 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -50.44 -55.18 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.624 1.17 . . . . 0.0 111.873 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.3 mt -68.35 -34.5 76.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.096 -1.003 . . . . 0.0 113.463 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -55.17 -41.63 72.12 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.648 0.658 . . . . 0.0 110.497 170.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 21.4 t -61.09 -41.14 96.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.821 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.7 mtp -67.59 -11.28 57.77 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.921 1.237 . . . . 0.0 114.298 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -127.76 -53.69 1.33 Allowed 'General case' 0 C--N 1.348 0.537 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -86.4 -2.35 58.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.85 -39.82 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.817 1.247 . . . . 0.0 111.472 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -49.54 -62.09 2.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.09 -54.74 4.74 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.017 3.145 . . . . 0.0 115.339 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 -37.18 26.06 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 121.913 1.719 . . . . 0.0 113.141 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.09 -50.52 66.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.888 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.2 ttm -58.32 -49.08 78.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.832 1.253 . . . . 0.0 111.401 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.94 90.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.277 1.031 . . . . 0.0 112.585 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.15 -51.27 68.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.75 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.9 mt . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 123.669 0.788 . . . . 0.0 111.817 -177.565 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.4 m -72.96 -37.58 67.03 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.657 0.783 . . . . 0.0 112.084 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mm -78.17 -46.08 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.016 0.927 . . . . 0.0 109.162 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.7 tp -45.62 -55.56 6.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.562 1.945 . . . . 0.0 111.761 162.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.21 77.93 Favored Glycine 0 CA--C 1.543 1.801 0 O-C-N 121.684 -0.635 . . . . 0.0 113.997 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.64 -46.3 89.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.887 1.343 . . . . 0.0 111.227 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.27 73.62 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.34 -51.1 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.264 0.938 . . . . 0.0 110.489 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.27 -46.08 65.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.96 0.904 . . . . 0.0 111.052 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.91 -58.56 7.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.619 0.767 . . . . 0.0 112.789 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.74 -49.82 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.539 1.136 . . . . 0.0 111.458 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.0 mt -50.64 -46.64 58.41 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.428 0.558 . . . . 0.0 112.424 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -56.6 -59.29 5.22 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.771 0.828 . . . . 0.0 111.885 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.26 -46.63 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.809 1.243 . . . . 0.0 112.469 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.54 -34.42 58.53 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -54.11 -44.88 71.67 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.653 0.66 . . . . 0.0 109.935 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.16 -42.8 91.6 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.517 -0.739 . . . . 0.0 111.625 166.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.7 ttm -65.43 -19.95 66.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -132.83 -45.55 0.87 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -71.04 -27.0 63.34 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.272 0.629 . . . . 0.0 112.062 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.68 -48.16 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.181 1.392 . . . . 0.0 111.61 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -46.65 -63.07 1.49 Allowed Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 -54.94 4.08 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.6 2.867 . . . . 0.0 115.322 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.65 -36.65 32.09 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 121.83 1.689 . . . . 0.0 113.133 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.1 -51.56 63.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.699 0.799 . . . . 0.0 110.55 168.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.3 ttm -57.36 -48.2 79.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.681 1.193 . . . . 0.0 111.477 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.33 92.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.024 0.929 . . . . 0.0 112.505 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.69 -50.69 70.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.872 1.269 . . . . 0.0 112.951 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.104 . . . . 0.0 112.117 -176.361 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -72.77 -37.5 67.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.77 0.828 . . . . 0.0 111.822 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.32 -46.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.372 1.069 . . . . 0.0 108.805 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.46 -55.4 6.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.476 1.91 . . . . 0.0 111.8 162.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.13 78.84 Favored Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.724 -0.61 . . . . 0.0 114.17 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -59.71 -46.57 88.69 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.083 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.1 -32.37 73.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.9 mm -62.32 -50.97 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.24 0.927 . . . . 0.0 110.461 170.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.25 -46.13 65.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.972 0.909 . . . . 0.0 111.077 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.81 -58.64 7.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.657 0.783 . . . . 0.0 112.746 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.53 -49.88 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.609 1.164 . . . . 0.0 111.409 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -50.72 -46.07 58.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.445 0.566 . . . . 0.0 112.509 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -56.8 -59.73 4.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.75 0.82 . . . . 0.0 111.749 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -51.67 -45.96 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.802 1.241 . . . . 0.0 112.539 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.17 -33.06 56.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -57.04 -41.51 78.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.702 0.683 . . . . 0.0 110.281 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.57 -44.64 93.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.421 -0.8 . . . . 0.0 111.351 164.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 39.9 ttm -63.54 -17.18 62.54 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -130.99 -47.98 1.02 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.63 -23.23 60.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.856 0.862 . . . . 0.0 112.329 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.98 -46.27 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.263 1.425 . . . . 0.0 111.391 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -48.31 -63.62 1.47 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.56 -54.53 5.01 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.716 2.944 . . . . 0.0 115.394 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.77 -37.42 27.96 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 CA-C-N 121.901 1.714 . . . . 0.0 113.09 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.8 tt -53.49 -50.65 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.657 0.783 . . . . 0.0 110.635 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.3 ttt -58.04 -49.71 75.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.575 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.97 -37.74 77.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 0.0 112.974 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -56.24 9.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.988 1.315 . . . . 0.0 112.468 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 CA--C 1.542 0.663 0 C-N-CA 124.638 1.175 . . . . 0.0 111.553 -177.914 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -74.06 -29.96 62.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.19 0.996 . . . . 0.0 112.338 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.9 mm -81.25 -48.24 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.091 0.956 . . . . 0.0 108.951 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.62 -55.42 6.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.744 2.018 . . . . 0.0 111.277 164.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.67 74.16 Favored Glycine 0 CA--C 1.543 1.788 0 O-C-N 121.707 -0.62 . . . . 0.0 114.019 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -62.41 -44.21 96.99 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.095 1.447 . . . . 0.0 111.52 166.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.03 -32.56 73.96 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.474 -0.767 . . . . 0.0 112.795 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.16 -51.18 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.988 0.915 . . . . 0.0 110.546 170.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.16 -46.36 65.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.851 0.86 . . . . 0.0 111.114 175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -61.41 -58.41 8.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.762 0.825 . . . . 0.0 112.763 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.28 -50.11 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.521 1.128 . . . . 0.0 111.359 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.56 -46.4 57.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -56.55 -59.36 5.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.725 0.81 . . . . 0.0 111.87 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.4 -44.8 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.843 1.257 . . . . 0.0 112.662 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.14 -34.32 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.37 -44.06 71.89 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.667 0.667 . . . . 0.0 110.091 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -46.18 86.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.547 -0.721 . . . . 0.0 111.239 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.2 ttm -63.15 -19.62 64.64 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -133.82 -45.02 0.8 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -71.7 -26.76 62.63 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.698 -0.626 . . . . 0.0 112.171 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -108.7 -47.84 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.104 1.362 . . . . 0.0 111.572 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -46.93 -62.85 1.67 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.68 -54.3 5.08 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.631 2.887 . . . . 0.0 115.409 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.16 -36.34 29.4 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 121.899 1.714 . . . . 0.0 113.019 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.7 -48.62 74.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.858 0.754 . . . . 0.0 111.352 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.4 ttt -58.21 -49.15 78.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.808 1.243 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.06 -44.5 87.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.414 1.086 . . . . 0.0 112.301 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.8 70.21 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.155 1.382 . . . . 0.0 112.894 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 124.282 1.033 . . . . 0.0 111.478 -178.665 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 113.353 0.872 . . . . 0.0 113.353 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.6 m -68.74 -33.72 74.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.191 0.596 . . . . 0.0 112.364 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.73 -47.27 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.114 0.966 . . . . 0.0 108.45 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.67 -56.09 5.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.621 1.968 . . . . 0.0 111.166 163.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.14 -31.06 74.21 Favored Glycine 0 CA--C 1.544 1.904 0 O-C-N 121.545 -0.722 . . . . 0.0 114.178 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -61.71 -44.3 97.19 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.897 1.349 . . . . 0.0 111.278 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.28 73.71 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.583 -0.698 . . . . 0.0 112.793 171.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.5 mm -62.34 -50.95 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.571 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.09 -46.37 65.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.903 0.881 . . . . 0.0 111.109 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -61.67 -58.55 7.62 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.709 0.804 . . . . 0.0 112.767 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.01 -49.84 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.523 1.129 . . . . 0.0 111.347 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.47 -46.69 57.01 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.4 -59.41 5.0 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.777 0.831 . . . . 0.0 111.786 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.39 -48.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.809 1.243 . . . . 0.0 112.317 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.53 -33.23 62.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -56.28 -43.79 79.15 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.679 0.672 . . . . 0.0 109.955 168.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.6 -38.97 86.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.764 -0.585 . . . . 0.0 111.919 166.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.1 ttm -64.74 -16.67 63.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.581 1.082 . . . . 0.0 113.634 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -126.76 -49.55 1.49 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -76.86 -18.57 58.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.895 0.878 . . . . 0.0 112.66 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.25 -43.16 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.728 1.211 . . . . 0.0 111.461 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -49.24 -62.11 2.75 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.59 -55.07 4.13 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.752 2.968 . . . . 0.0 115.414 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.94 -37.52 26.35 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.83 1.687 . . . . 0.0 112.931 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.7 tp -54.06 -50.16 67.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.719 0.691 . . . . 0.0 111.168 169.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.9 ttm -57.93 -49.65 76.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.736 1.214 . . . . 0.0 111.471 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.93 -46.86 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.304 1.042 . . . . 0.0 111.878 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.3 57.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.851 1.26 . . . . 0.0 112.996 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 125.219 1.408 . . . . 0.0 112.711 -175.71 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m -71.44 -37.99 71.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.156 0.983 . . . . 0.0 111.811 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.46 -46.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 108.84 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -45.15 -56.33 4.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.663 1.985 . . . . 0.0 111.823 161.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.05 -31.49 78.01 Favored Glycine 0 CA--C 1.545 1.908 0 O-C-N 121.629 -0.67 . . . . 0.0 114.188 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -60.36 -46.65 89.19 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.672 1.236 . . . . 0.0 110.978 166.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.07 73.28 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 172.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.8 mm -62.57 -51.54 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 119.255 0.934 . . . . 0.0 110.562 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.97 -45.25 64.35 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.048 0.939 . . . . 0.0 111.22 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.73 -59.51 4.8 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.676 0.79 . . . . 0.0 112.693 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.41 -48.87 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.668 1.187 . . . . 0.0 111.571 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.8 mt -50.67 -48.2 58.55 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.459 0.572 . . . . 0.0 112.315 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -56.13 -58.44 7.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.952 0.901 . . . . 0.0 111.931 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.1 -54.91 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.678 1.191 . . . . 0.0 111.79 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.4 mt -70.76 -32.39 69.52 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.83 -40.77 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.849 0.75 . . . . 0.0 110.434 167.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.6 t -61.05 -42.3 98.23 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.369 -0.832 . . . . 0.0 111.733 165.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.6 mtt -68.74 -11.47 60.33 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -133.0 -48.26 0.86 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -72.94 -23.02 60.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.917 0.887 . . . . 0.0 112.315 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.87 -46.02 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.289 1.436 . . . . 0.0 111.319 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -47.95 -63.4 1.52 Allowed Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.62 -54.76 4.59 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.764 2.976 . . . . 0.0 115.444 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.11 -35.96 31.36 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 CA-C-N 121.824 1.687 . . . . 0.0 113.164 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.94 -48.89 74.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.773 0.715 . . . . 0.0 111.265 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt -58.49 -46.96 85.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.802 1.241 . . . . 0.0 111.798 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.47 92.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.659 1.184 . . . . 0.0 112.466 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.41 -49.68 74.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.998 1.319 . . . . 0.0 112.724 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 124.465 1.106 . . . . 0.0 111.225 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.5 m -73.33 -30.5 63.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.337 0.655 . . . . 0.0 112.299 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.02 -53.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.286 1.034 . . . . 0.0 108.502 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -40.51 -56.71 2.0 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.371 2.268 . . . . 0.0 111.846 161.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.7 -30.21 77.31 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 123.32 0.486 . . . . 0.0 114.066 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -47.44 84.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.813 1.306 . . . . 0.0 111.036 167.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.24 72.31 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.73 -51.42 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.287 0.949 . . . . 0.0 110.566 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.2 -44.9 64.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.932 0.893 . . . . 0.0 111.221 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -63.09 -59.0 5.38 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.686 0.794 . . . . 0.0 112.704 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.42 -49.5 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.556 1.142 . . . . 0.0 111.458 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.95 -46.17 60.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.457 0.571 . . . . 0.0 112.446 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.01 -59.34 5.21 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.766 0.826 . . . . 0.0 111.793 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.07 -47.75 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.892 1.277 . . . . 0.0 112.329 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.46 -33.84 60.88 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.35 -42.03 77.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.65 0.659 . . . . 0.0 110.319 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.5 t -61.03 -40.88 95.28 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.554 -0.716 . . . . 0.0 111.628 165.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.7 ttm -65.98 -17.21 64.53 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.556 1.071 . . . . 0.0 113.87 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -129.73 -48.24 1.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.7 -23.21 60.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.992 0.917 . . . . 0.0 112.315 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.98 -45.16 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.335 1.454 . . . . 0.0 111.458 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -48.2 -62.58 2.09 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.71 -54.71 4.67 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.772 2.981 . . . . 0.0 115.33 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.18 -36.52 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 CA-C-N 121.852 1.697 . . . . 0.0 113.179 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.39 -50.66 67.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.988 0.915 . . . . 0.0 110.756 169.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -58.18 -48.34 80.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.733 1.213 . . . . 0.0 111.62 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.99 91.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.323 1.049 . . . . 0.0 112.587 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.32 68.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.926 1.291 . . . . 0.0 112.79 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt . . . . . 0 CA--C 1.543 0.68 0 C-N-CA 123.714 0.805 . . . . 0.0 111.779 -178.089 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.3 m -72.51 -32.47 66.19 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.39 0.676 . . . . 0.0 112.361 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.6 mm -79.52 -47.33 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.804 0.841 . . . . 0.0 109.054 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -46.17 -57.08 4.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.92 2.088 . . . . 0.0 111.25 163.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.03 -29.87 75.17 Favored Glycine 0 CA--C 1.544 1.878 0 O-C-N 121.682 -0.636 . . . . 0.0 114.05 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -62.97 -44.83 94.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.983 1.391 . . . . 0.0 111.132 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.23 73.02 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.584 -0.698 . . . . 0.0 112.801 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.3 mm -62.51 -51.29 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.146 0.885 . . . . 0.0 110.584 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.33 65.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 111.134 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -62.02 -58.86 6.25 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.868 0.867 . . . . 0.0 112.741 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.14 -49.53 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.518 1.127 . . . . 0.0 111.399 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.2 mt -50.58 -47.88 57.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.394 0.543 . . . . 0.0 112.358 172.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -55.64 -58.23 8.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.901 0.88 . . . . 0.0 111.994 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.6 -54.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.59 1.156 . . . . 0.0 111.826 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.48 -36.03 76.14 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.119 -0.988 . . . . 0.0 113.539 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -52.56 -44.28 65.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.693 0.679 . . . . 0.0 110.049 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.5 t -60.68 -40.38 91.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.917 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.7 mtp -73.3 -13.12 61.06 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.083 1.311 . . . . 0.0 114.463 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -139.74 -43.81 0.44 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.3 -28.51 64.17 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.738 -0.601 . . . . 0.0 111.864 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.98 -51.33 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.312 1.445 . . . . 0.0 111.566 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -45.98 -62.67 1.66 Allowed Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.12 -55.48 3.39 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.38 2.72 . . . . 0.0 115.316 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.02 -36.57 29.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.881 1.721 . . . . 0.0 113.092 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.9 tp -53.57 -50.33 65.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.388 0.675 . . . . 0.0 111.14 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -58.39 -48.24 81.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.282 1.033 . . . . 0.0 111.591 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.78 76.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.031 0.932 . . . . 0.0 111.742 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.27 -54.22 43.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 112.942 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 mm . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 125.281 1.433 . . . . 0.0 112.906 -176.148 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.3 m -69.01 -41.85 77.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.023 0.929 . . . . 0.0 112.989 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.55 -43.94 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.078 0.854 . . . . 0.0 109.132 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.0 tp -46.42 -55.38 7.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.266 1.826 . . . . 0.0 111.955 163.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -32.27 75.76 Favored Glycine 0 CA--C 1.542 1.778 0 O-C-N 121.637 -0.664 . . . . 0.0 114.067 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.01 -45.56 92.35 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.016 -1.285 . . . . 0.0 111.326 165.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.48 73.94 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.4 mm -62.09 -50.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.074 0.949 . . . . 0.0 110.483 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.23 65.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.916 0.887 . . . . 0.0 111.103 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.88 -58.42 8.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.661 0.784 . . . . 0.0 112.72 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.22 -50.2 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.528 1.131 . . . . 0.0 111.386 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.44 -46.22 56.41 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.71 -59.06 5.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.25 -45.87 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.585 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.91 -34.68 57.69 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.257 -0.902 . . . . 0.0 113.419 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -54.48 -44.25 72.47 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.635 0.652 . . . . 0.0 110.059 166.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -58.28 -45.83 87.16 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.579 -0.7 . . . . 0.0 111.256 165.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.7 ttp -63.5 -19.4 64.73 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -134.69 -45.28 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -71.26 -27.01 63.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.721 -0.612 . . . . 0.0 112.089 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.3 -48.42 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.073 1.349 . . . . 0.0 111.568 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -47.1 -63.0 1.58 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.7 -54.92 4.05 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.51 2.807 . . . . 0.0 115.32 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.55 -35.47 38.22 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 CA-C-N 121.873 1.704 . . . . 0.0 113.126 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.0 tp -55.92 -49.73 72.66 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.913 0.778 . . . . 0.0 111.278 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.2 ttm -58.46 -45.2 89.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.271 1.429 . . . . 0.0 111.911 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.7 85.05 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.475 1.11 . . . . 0.0 112.225 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.78 80.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.178 1.391 . . . . 0.0 112.74 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.544 0.733 0 C-N-CA 124.465 1.106 . . . . 0.0 110.937 174.187 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.3 m -73.21 -32.43 64.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.224 0.61 . . . . 0.0 112.223 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.0 mt -77.42 -49.89 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.143 0.977 . . . . 0.0 108.648 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 tt -44.02 -58.0 3.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.431 2.292 . . . . 0.0 111.14 163.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.07 -30.11 76.29 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 121.619 -0.675 . . . . 0.0 114.067 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.56 -45.13 94.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.031 1.416 . . . . 0.0 110.826 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.12 -32.0 73.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.348 0.659 . . . . 0.0 112.702 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.49 -51.74 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.225 0.92 . . . . 0.0 110.59 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -44.56 64.4 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.038 0.935 . . . . 0.0 111.348 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.72 -59.21 4.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 112.685 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.25 -49.19 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.658 1.183 . . . . 0.0 111.469 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.44 -47.66 56.65 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.504 0.593 . . . . 0.0 112.377 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -56.39 -58.44 7.99 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.076 0.95 . . . . 0.0 111.91 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -50.34 -54.15 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.639 1.176 . . . . 0.0 111.767 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.18 -35.03 73.67 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.988 -1.07 . . . . 0.0 113.577 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.64 -42.8 68.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.669 0.668 . . . . 0.0 110.252 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 t -59.58 -45.69 91.14 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.473 -0.767 . . . . 0.0 111.362 166.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.9 mtp -69.38 -12.09 61.36 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.2 -40.04 0.44 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -173.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -75.45 -28.3 59.26 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.59 0.632 . . . . 0.0 111.627 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.77 -49.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.249 1.419 . . . . 0.0 111.316 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -46.79 -61.32 2.83 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.37 -54.84 4.0 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.319 2.68 . . . . 0.0 115.338 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.96 -37.5 26.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 121.922 1.722 . . . . 0.0 113.007 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.0 tp -54.35 -48.07 71.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.484 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.25 -50.48 73.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.547 1.139 . . . . 0.0 111.403 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.25 73.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 113.119 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.27 4.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.013 1.325 . . . . 0.0 112.156 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.3 mt . . . . . 0 CA--C 1.542 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 111.08 -178.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 121.027 0.441 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -77.05 63.24 2.31 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.784 1.234 . . . . 0.0 111.31 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.55 62.36 6.77 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.841 1.656 . . . . 0.0 109.194 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -26.75 -60.23 0.09 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.65 2.78 . . . . 0.0 114.167 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.75 -37.16 50.06 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.088 1.755 . . . . 0.0 113.677 -178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.8 m -73.27 -32.05 64.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.676 0.79 . . . . 0.0 112.509 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -80.08 -48.59 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.815 0.846 . . . . 0.0 109.096 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.6 tp -44.81 -56.89 4.11 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.848 2.059 . . . . 0.0 111.708 162.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.23 -31.53 79.42 Favored Glycine 0 CA--C 1.544 1.858 0 O-C-N 121.779 -0.575 . . . . 0.0 113.95 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -61.29 -45.58 93.89 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.884 1.342 . . . . 0.0 111.027 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.38 73.76 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 mm -62.31 -51.32 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 119.304 0.956 . . . . 0.0 110.48 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -45.22 65.24 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.051 0.94 . . . . 0.0 111.222 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.88 -59.33 4.99 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.634 0.774 . . . . 0.0 112.666 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.89 -50.12 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 124.661 1.185 . . . . 0.0 111.293 -173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.4 mt -50.23 -47.31 55.04 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.494 0.588 . . . . 0.0 112.411 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -56.06 -58.51 7.62 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.907 0.883 . . . . 0.0 111.886 174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -50.44 -55.18 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.624 1.17 . . . . 0.0 111.873 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.3 mt -68.35 -34.5 76.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.096 -1.003 . . . . 0.0 113.463 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -55.17 -41.63 72.12 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.648 0.658 . . . . 0.0 110.497 170.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 21.4 t -61.09 -41.14 96.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 118.924 -0.56 . . . . 0.0 111.821 166.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.7 mtp -67.59 -11.28 57.77 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.921 1.237 . . . . 0.0 114.298 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -127.76 -53.69 1.33 Allowed 'General case' 0 C--N 1.348 0.537 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -86.4 -2.35 58.35 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.937 0.895 . . . . 0.0 113.235 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.85 -39.82 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.817 1.247 . . . . 0.0 111.472 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -49.54 -62.09 2.84 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.09 -54.74 4.74 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 124.017 3.145 . . . . 0.0 115.339 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.16 -37.18 26.06 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 121.913 1.719 . . . . 0.0 113.141 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.09 -50.52 66.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.818 0.847 . . . . 0.0 110.888 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 49.2 ttm -58.32 -49.08 78.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.832 1.253 . . . . 0.0 111.401 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.76 -42.94 90.08 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.277 1.031 . . . . 0.0 112.585 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.15 -51.27 68.54 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.88 1.272 . . . . 0.0 112.75 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 52.9 mt -77.63 -54.66 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.669 0.788 . . . . 0.0 111.817 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -73.67 64.87 0.94 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.874 1.27 . . . . 0.0 111.419 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.37 88.47 1.01 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.534 1.534 . . . . 0.0 108.496 -177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -35.76 -59.82 0.56 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.888 2.075 . . . . 0.0 113.336 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.26 -33.4 41.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.91 1.684 . . . . 0.0 113.523 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.4 m -72.96 -37.58 67.03 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.657 0.783 . . . . 0.0 112.084 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.8 mm -78.17 -46.08 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.016 0.927 . . . . 0.0 109.162 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.7 tp -45.62 -55.56 6.2 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.562 1.945 . . . . 0.0 111.761 162.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.64 -32.21 77.93 Favored Glycine 0 CA--C 1.543 1.801 0 O-C-N 121.684 -0.635 . . . . 0.0 113.997 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -59.64 -46.3 89.4 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.887 1.343 . . . . 0.0 111.227 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.18 -32.27 73.62 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 172.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.2 mm -62.34 -51.1 76.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.264 0.938 . . . . 0.0 110.489 170.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.27 -46.08 65.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.96 0.904 . . . . 0.0 111.052 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.91 -58.56 7.44 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.619 0.767 . . . . 0.0 112.789 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.74 -49.82 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.539 1.136 . . . . 0.0 111.458 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.0 mt -50.64 -46.64 58.41 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.428 0.558 . . . . 0.0 112.424 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -56.6 -59.29 5.22 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.771 0.828 . . . . 0.0 111.885 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.26 -46.63 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.809 1.243 . . . . 0.0 112.469 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.54 -34.42 58.53 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -54.11 -44.88 71.67 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.653 0.66 . . . . 0.0 109.935 166.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 24.0 t -59.16 -42.8 91.6 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.517 -0.739 . . . . 0.0 111.625 166.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.7 ttm -65.43 -19.95 66.16 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -132.83 -45.55 0.87 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -71.04 -27.0 63.34 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.272 0.629 . . . . 0.0 112.062 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.5 t -108.68 -48.16 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 125.181 1.392 . . . . 0.0 111.61 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -46.65 -63.07 1.49 Allowed Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 -54.94 4.08 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 123.6 2.867 . . . . 0.0 115.322 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.65 -36.65 32.09 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 121.83 1.689 . . . . 0.0 113.133 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -54.1 -51.56 63.79 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.699 0.799 . . . . 0.0 110.55 168.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.3 ttm -57.36 -48.2 79.64 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.681 1.193 . . . . 0.0 111.477 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.3 -44.33 92.53 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.024 0.929 . . . . 0.0 112.505 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.69 -50.69 70.16 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.872 1.269 . . . . 0.0 112.951 177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.8 mm -77.99 -52.52 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.461 1.104 . . . . 0.0 112.117 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.8 mtm . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 121.019 0.438 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -67.99 133.74 49.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.405 1.082 . . . . 0.0 111.568 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -79.44 53.46 1.55 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.613 1.165 . . . . 0.0 109.887 171.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -48.69 -54.28 15.45 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.174 1.79 . . . . 0.0 112.668 -170.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.3 -33.63 20.75 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.016 1.726 . . . . 0.0 113.823 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 m -72.77 -37.5 67.62 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.77 0.828 . . . . 0.0 111.822 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 76.8 mt -78.32 -46.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.372 1.069 . . . . 0.0 108.805 -176.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.1 tp -45.46 -55.4 6.19 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.476 1.91 . . . . 0.0 111.8 162.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.32 -32.13 78.84 Favored Glycine 0 CA--C 1.544 1.9 0 O-C-N 121.724 -0.61 . . . . 0.0 114.17 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -59.71 -46.57 88.69 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.705 1.253 . . . . 0.0 111.083 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.1 -32.37 73.73 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.9 mm -62.32 -50.97 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 119.24 0.927 . . . . 0.0 110.461 170.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.25 -46.13 65.64 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.972 0.909 . . . . 0.0 111.077 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -61.81 -58.64 7.19 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.657 0.783 . . . . 0.0 112.746 174.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.53 -49.88 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.609 1.164 . . . . 0.0 111.409 -173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -50.72 -46.07 58.86 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.445 0.566 . . . . 0.0 112.509 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -56.8 -59.73 4.6 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.75 0.82 . . . . 0.0 111.749 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.9 t -51.67 -45.96 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.802 1.241 . . . . 0.0 112.539 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.17 -33.06 56.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -57.04 -41.51 78.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.702 0.683 . . . . 0.0 110.281 167.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.5 t -59.57 -44.64 93.23 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.421 -0.8 . . . . 0.0 111.351 164.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 39.9 ttm -63.54 -17.18 62.54 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -130.99 -47.98 1.02 Allowed 'General case' 0 C--N 1.348 0.518 0 N-CA-C 115.532 1.679 . . . . 0.0 115.532 -173.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.63 -23.23 60.89 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.856 0.862 . . . . 0.0 112.329 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.98 -46.27 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.263 1.425 . . . . 0.0 111.391 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 12.3 m0 -48.31 -63.62 1.47 Allowed Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.56 -54.53 5.01 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.716 2.944 . . . . 0.0 115.394 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.77 -37.42 27.96 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 CA-C-N 121.901 1.714 . . . . 0.0 113.09 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.8 tt -53.49 -50.65 64.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.657 0.783 . . . . 0.0 110.635 168.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.3 ttt -58.04 -49.71 75.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.575 178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.97 -37.74 77.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.603 1.161 . . . . 0.0 112.974 176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -56.24 9.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.988 1.315 . . . . 0.0 112.468 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm -67.01 -52.05 47.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.638 1.175 . . . . 0.0 111.553 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 121.216 0.532 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -81.0 55.54 2.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.923 1.289 . . . . 0.0 111.776 -175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.37 47.64 1.06 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.396 1.078 . . . . 0.0 110.984 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -57.09 -43.77 82.51 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.754 2.022 . . . . 0.0 112.196 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.68 25.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.468 1.507 . . . . 0.0 113.537 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 m -74.06 -29.96 62.15 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.19 0.996 . . . . 0.0 112.338 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.9 mm -81.25 -48.24 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.091 0.956 . . . . 0.0 108.951 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -45.62 -55.42 6.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.744 2.018 . . . . 0.0 111.277 164.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.04 -30.67 74.16 Favored Glycine 0 CA--C 1.543 1.788 0 O-C-N 121.707 -0.62 . . . . 0.0 114.019 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -62.41 -44.21 96.99 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 119.095 1.447 . . . . 0.0 111.52 166.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.03 -32.56 73.96 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.474 -0.767 . . . . 0.0 112.795 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 mm -62.16 -51.18 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 123.988 0.915 . . . . 0.0 110.546 170.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.16 -46.36 65.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.851 0.86 . . . . 0.0 111.114 175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -61.41 -58.41 8.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.762 0.825 . . . . 0.0 112.763 175.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.28 -50.11 80.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.521 1.128 . . . . 0.0 111.359 -174.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.56 -46.4 57.57 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 173.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -56.55 -59.36 5.1 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.725 0.81 . . . . 0.0 111.87 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.4 -44.8 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.843 1.257 . . . . 0.0 112.662 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.14 -34.32 49.9 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.37 -44.06 71.89 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.667 0.667 . . . . 0.0 110.091 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -46.18 86.81 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.547 -0.721 . . . . 0.0 111.239 165.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 41.2 ttm -63.15 -19.62 64.64 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -133.82 -45.02 0.8 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -71.7 -26.76 62.63 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.698 -0.626 . . . . 0.0 112.171 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.9 t -108.7 -47.84 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.104 1.362 . . . . 0.0 111.572 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -46.93 -62.85 1.67 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.68 -54.3 5.08 Favored 'Trans proline' 0 CA--C 1.547 1.132 0 C-N-CA 123.631 2.887 . . . . 0.0 115.409 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.16 -36.34 29.4 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 121.899 1.714 . . . . 0.0 113.019 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 34.4 tp -55.7 -48.62 74.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.858 0.754 . . . . 0.0 111.352 169.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.4 ttt -58.21 -49.15 78.08 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.808 1.243 . . . . 0.0 111.524 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.06 -44.5 87.49 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.414 1.086 . . . . 0.0 112.301 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.3 -50.8 70.21 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.155 1.382 . . . . 0.0 112.894 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.22 -55.61 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.282 1.033 . . . . 0.0 111.478 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 tpt . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -161.6 155.11 21.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.701 1.2 . . . . 0.0 110.523 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.5 tt -77.29 52.77 0.95 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.384 1.474 . . . . 0.0 111.252 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -167.06 -71.27 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 129.247 3.019 . . . . 0.0 107.179 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.71 70.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.804 1.641 . . . . 0.0 113.353 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.6 m -68.74 -33.72 74.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.191 0.596 . . . . 0.0 112.364 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 mp -79.73 -47.27 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.114 0.966 . . . . 0.0 108.45 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.67 -56.09 5.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.621 1.968 . . . . 0.0 111.166 163.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.14 -31.06 74.21 Favored Glycine 0 CA--C 1.544 1.904 0 O-C-N 121.545 -0.722 . . . . 0.0 114.178 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -61.71 -44.3 97.19 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.897 1.349 . . . . 0.0 111.278 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.64 -32.28 73.71 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.583 -0.698 . . . . 0.0 112.793 171.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.5 mm -62.34 -50.95 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.571 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.09 -46.37 65.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.903 0.881 . . . . 0.0 111.109 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -61.67 -58.55 7.62 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.709 0.804 . . . . 0.0 112.767 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.01 -49.84 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.523 1.129 . . . . 0.0 111.347 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.8 mt -50.47 -46.69 57.01 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.4 -59.41 5.0 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.777 0.831 . . . . 0.0 111.786 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.39 -48.21 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.809 1.243 . . . . 0.0 112.317 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.4 mt -74.53 -33.23 62.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -56.28 -43.79 79.15 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.679 0.672 . . . . 0.0 109.955 168.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.0 t -60.6 -38.97 86.43 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.764 -0.585 . . . . 0.0 111.919 166.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 42.1 ttm -64.74 -16.67 63.29 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.581 1.082 . . . . 0.0 113.634 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -126.76 -49.55 1.49 Allowed 'General case' 0 C--N 1.349 0.57 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -173.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -76.86 -18.57 58.27 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.895 0.878 . . . . 0.0 112.66 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.6 t -111.25 -43.16 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.728 1.211 . . . . 0.0 111.461 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -49.24 -62.11 2.75 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.59 -55.07 4.13 Favored 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 123.752 2.968 . . . . 0.0 115.414 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.94 -37.52 26.35 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 121.83 1.687 . . . . 0.0 112.931 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.7 tp -54.06 -50.16 67.36 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.719 0.691 . . . . 0.0 111.168 169.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.9 ttm -57.93 -49.65 76.03 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.736 1.214 . . . . 0.0 111.471 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.93 -46.86 78.36 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.304 1.042 . . . . 0.0 111.878 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.35 -53.3 57.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.851 1.26 . . . . 0.0 112.996 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.0 mm -70.2 -44.56 77.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 125.219 1.408 . . . . 0.0 112.711 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mtp . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -76.63 63.94 2.18 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.826 1.25 . . . . 0.0 111.873 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.17 56.66 3.26 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.713 1.605 . . . . 0.0 110.187 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -31.8 -69.59 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.933 2.493 . . . . 0.0 113.778 -173.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.28 -35.75 65.38 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.307 1.443 . . . . 0.0 113.883 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.6 m -71.44 -37.99 71.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.156 0.983 . . . . 0.0 111.811 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 83.6 mt -78.46 -46.25 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.525 1.13 . . . . 0.0 108.84 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.0 tp -45.15 -56.33 4.87 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.663 1.985 . . . . 0.0 111.823 161.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.05 -31.49 78.01 Favored Glycine 0 CA--C 1.545 1.908 0 O-C-N 121.629 -0.67 . . . . 0.0 114.188 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -60.36 -46.65 89.19 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.672 1.236 . . . . 0.0 110.978 166.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.07 73.28 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 172.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.8 mm -62.57 -51.54 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 119.255 0.934 . . . . 0.0 110.562 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -51.97 -45.25 64.35 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.048 0.939 . . . . 0.0 111.22 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -62.73 -59.51 4.8 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.676 0.79 . . . . 0.0 112.693 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.41 -48.87 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 124.668 1.187 . . . . 0.0 111.571 -173.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.8 mt -50.67 -48.2 58.55 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.459 0.572 . . . . 0.0 112.315 172.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -56.13 -58.44 7.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.952 0.901 . . . . 0.0 111.931 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.6 t -50.1 -54.91 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.678 1.191 . . . . 0.0 111.79 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 75.4 mt -70.76 -32.39 69.52 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -55.83 -40.77 73.28 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.849 0.75 . . . . 0.0 110.434 167.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.6 t -61.05 -42.3 98.23 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.369 -0.832 . . . . 0.0 111.733 165.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 51.6 mtt -68.74 -11.47 60.33 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -133.0 -48.26 0.86 Allowed 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -72.94 -23.02 60.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.917 0.887 . . . . 0.0 112.315 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -110.87 -46.02 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.289 1.436 . . . . 0.0 111.319 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -47.95 -63.4 1.52 Allowed Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.62 -54.76 4.59 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.764 2.976 . . . . 0.0 115.444 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.11 -35.96 31.36 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 CA-C-N 121.824 1.687 . . . . 0.0 113.164 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.2 tp -55.94 -48.89 74.91 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.773 0.715 . . . . 0.0 111.265 169.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.2 tpt -58.49 -46.96 85.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.802 1.241 . . . . 0.0 111.798 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.33 -44.47 92.6 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.659 1.184 . . . . 0.0 112.466 174.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.41 -49.68 74.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.998 1.319 . . . . 0.0 112.724 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.0 -60.56 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.465 1.106 . . . . 0.0 111.225 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -77.33 62.06 2.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.749 1.22 . . . . 0.0 111.453 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 tt -83.74 63.4 7.44 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.784 1.634 . . . . 0.0 108.974 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -22.68 -65.66 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 129.061 2.944 . . . . 0.0 114.136 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.69 -39.52 65.23 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.417 1.487 . . . . 0.0 113.622 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 94.5 m -73.33 -30.5 63.39 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.337 0.655 . . . . 0.0 112.299 175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.0 mt -79.02 -53.54 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.286 1.034 . . . . 0.0 108.502 -177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.8 tp -40.51 -56.71 2.0 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.371 2.268 . . . . 0.0 111.846 161.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -64.7 -30.21 77.31 Favored Glycine 0 CA--C 1.543 1.827 0 C-N-CA 123.32 0.486 . . . . 0.0 114.066 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -47.44 84.81 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.813 1.306 . . . . 0.0 111.036 167.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -32.24 72.31 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 171.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -62.73 -51.42 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.287 0.949 . . . . 0.0 110.566 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.2 -44.9 64.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.932 0.893 . . . . 0.0 111.221 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -63.09 -59.0 5.38 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.686 0.794 . . . . 0.0 112.704 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -63.42 -49.5 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 124.556 1.142 . . . . 0.0 111.458 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.95 -46.17 60.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.457 0.571 . . . . 0.0 112.446 173.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.01 -59.34 5.21 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.766 0.826 . . . . 0.0 111.793 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.07 -47.75 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.892 1.277 . . . . 0.0 112.329 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.46 -33.84 60.88 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -56.35 -42.03 77.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.65 0.659 . . . . 0.0 110.319 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.5 t -61.03 -40.88 95.28 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.554 -0.716 . . . . 0.0 111.628 165.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 40.7 ttm -65.98 -17.21 64.53 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.556 1.071 . . . . 0.0 113.87 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -129.73 -48.24 1.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -173.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -72.7 -23.21 60.84 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.992 0.917 . . . . 0.0 112.315 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.98 -45.16 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.335 1.454 . . . . 0.0 111.458 -174.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -48.2 -62.58 2.09 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.71 -54.71 4.67 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.772 2.981 . . . . 0.0 115.33 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.18 -36.52 28.48 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 CA-C-N 121.852 1.697 . . . . 0.0 113.179 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.39 -50.66 67.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.988 0.915 . . . . 0.0 110.756 169.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -58.18 -48.34 80.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.733 1.213 . . . . 0.0 111.62 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.99 91.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.323 1.049 . . . . 0.0 112.587 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.25 -51.32 68.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.926 1.291 . . . . 0.0 112.79 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 51.2 mt -76.27 -55.66 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 123.714 0.805 . . . . 0.0 111.779 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.6 ttm . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -81.44 59.91 4.25 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.941 1.296 . . . . 0.0 111.445 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 tt -157.21 87.32 0.98 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.355 1.462 . . . . 0.0 108.637 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -43.29 -49.92 6.68 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.077 1.751 . . . . 0.0 113.173 -174.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.08 -34.4 60.05 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.994 1.318 . . . . 0.0 113.416 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 95.3 m -72.51 -32.47 66.19 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.39 0.676 . . . . 0.0 112.361 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.6 mm -79.52 -47.33 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.804 0.841 . . . . 0.0 109.054 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -46.17 -57.08 4.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.92 2.088 . . . . 0.0 111.25 163.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.03 -29.87 75.17 Favored Glycine 0 CA--C 1.544 1.878 0 O-C-N 121.682 -0.636 . . . . 0.0 114.05 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.5 tp-100 -62.97 -44.83 94.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.983 1.391 . . . . 0.0 111.132 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.38 -32.23 73.02 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.584 -0.698 . . . . 0.0 112.801 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.3 mm -62.51 -51.29 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.146 0.885 . . . . 0.0 110.584 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.07 -46.33 65.12 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.912 0.885 . . . . 0.0 111.134 175.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -62.02 -58.86 6.25 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.868 0.867 . . . . 0.0 112.741 175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.14 -49.53 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.518 1.127 . . . . 0.0 111.399 -173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.2 mt -50.58 -47.88 57.84 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.394 0.543 . . . . 0.0 112.358 172.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -55.64 -58.23 8.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.901 0.88 . . . . 0.0 111.994 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.9 t -50.6 -54.77 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.59 1.156 . . . . 0.0 111.826 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.5 mt -69.48 -36.03 76.14 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.119 -0.988 . . . . 0.0 113.539 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -52.56 -44.28 65.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.693 0.679 . . . . 0.0 110.049 167.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.5 t -60.68 -40.38 91.92 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.917 168.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 89.7 mtp -73.3 -13.12 61.06 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.083 1.311 . . . . 0.0 114.463 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -139.74 -43.81 0.44 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 -172.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -71.3 -28.51 64.17 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.738 -0.601 . . . . 0.0 111.864 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.98 -51.33 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.312 1.445 . . . . 0.0 111.566 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -45.98 -62.67 1.66 Allowed Pre-proline 0 CA--C 1.549 0.942 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.12 -55.48 3.39 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 123.38 2.72 . . . . 0.0 115.316 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.02 -36.57 29.52 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.881 1.721 . . . . 0.0 113.092 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 42.9 tp -53.57 -50.33 65.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.388 0.675 . . . . 0.0 111.14 168.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -58.39 -48.24 81.27 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.282 1.033 . . . . 0.0 111.591 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.5 -46.78 76.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.031 0.932 . . . . 0.0 111.742 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.27 -54.22 43.85 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 112.942 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 28.3 mm -68.77 -41.33 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.281 1.433 . . . . 0.0 112.906 -176.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.167 0.508 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -162.28 152.3 16.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.38 1.472 . . . . 0.0 110.092 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -51.26 -51.65 52.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.122 1.369 . . . . 0.0 110.836 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -47.37 -61.76 1.75 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.818 1.247 . . . . 0.0 111.278 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.6 -36.25 55.84 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.702 1.601 . . . . 0.0 113.438 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.3 m -69.01 -41.85 77.2 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.023 0.929 . . . . 0.0 112.989 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.5 mm -77.55 -43.94 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.078 0.854 . . . . 0.0 109.132 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.0 tp -46.42 -55.38 7.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.266 1.826 . . . . 0.0 111.955 163.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -32.27 75.76 Favored Glycine 0 CA--C 1.542 1.778 0 O-C-N 121.637 -0.664 . . . . 0.0 114.067 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -60.01 -45.56 92.35 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.016 -1.285 . . . . 0.0 111.326 165.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.48 73.94 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.4 mm -62.09 -50.92 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.074 0.949 . . . . 0.0 110.483 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.24 -46.23 65.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.916 0.887 . . . . 0.0 111.103 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -61.88 -58.42 8.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.661 0.784 . . . . 0.0 112.72 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.22 -50.2 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.528 1.131 . . . . 0.0 111.386 -173.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.6 mt -50.44 -46.22 56.41 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -56.71 -59.06 5.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.25 -45.87 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.585 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 76.8 mt -76.91 -34.68 57.69 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.257 -0.902 . . . . 0.0 113.419 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -54.48 -44.25 72.47 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.635 0.652 . . . . 0.0 110.059 166.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.1 t -58.28 -45.83 87.16 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.579 -0.7 . . . . 0.0 111.256 165.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 31.7 ttp -63.5 -19.4 64.73 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -134.69 -45.28 0.74 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -71.26 -27.01 63.14 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.721 -0.612 . . . . 0.0 112.089 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.3 -48.42 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.073 1.349 . . . . 0.0 111.568 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.8 m0 -47.1 -63.0 1.58 Allowed Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.7 -54.92 4.05 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 123.51 2.807 . . . . 0.0 115.32 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.55 -35.47 38.22 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 CA-C-N 121.873 1.704 . . . . 0.0 113.126 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 39.0 tp -55.92 -49.73 72.66 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.913 0.778 . . . . 0.0 111.278 168.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 50.2 ttm -58.46 -45.2 89.07 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.271 1.429 . . . . 0.0 111.911 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -47.7 85.05 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.475 1.11 . . . . 0.0 112.225 174.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.43 -48.78 80.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.178 1.391 . . . . 0.0 112.74 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.22 -49.15 82.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 124.465 1.106 . . . . 0.0 110.937 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mtp . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -128.67 56.33 1.66 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.73 1.612 . . . . 0.0 109.476 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 tt -170.55 100.56 0.25 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.567 1.947 . . . . 0.0 106.967 -172.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -27.76 -64.47 0.09 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.583 2.353 . . . . 0.0 113.569 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.23 -35.39 64.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.085 1.354 . . . . 0.0 113.77 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.3 m -73.21 -32.43 64.77 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.224 0.61 . . . . 0.0 112.223 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 75.0 mt -77.42 -49.89 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.143 0.977 . . . . 0.0 108.648 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 tt -44.02 -58.0 3.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.431 2.292 . . . . 0.0 111.14 163.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.07 -30.11 76.29 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 121.619 -0.675 . . . . 0.0 114.067 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.56 -45.13 94.36 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.031 1.416 . . . . 0.0 110.826 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.12 -32.0 73.27 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.348 0.659 . . . . 0.0 112.702 172.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.5 mm -62.49 -51.74 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 119.225 0.92 . . . . 0.0 110.59 170.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -44.56 64.4 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.038 0.935 . . . . 0.0 111.348 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.72 -59.21 4.87 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.731 0.812 . . . . 0.0 112.685 174.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.5 t -63.25 -49.19 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.658 1.183 . . . . 0.0 111.469 -173.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.4 mt -50.44 -47.66 56.65 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 118.504 0.593 . . . . 0.0 112.377 173.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -56.39 -58.44 7.99 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.076 0.95 . . . . 0.0 111.91 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.5 t -50.34 -54.15 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.639 1.176 . . . . 0.0 111.767 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.18 -35.03 73.67 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 120.988 -1.07 . . . . 0.0 113.577 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -53.64 -42.8 68.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.669 0.668 . . . . 0.0 110.252 168.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.2 t -59.58 -45.69 91.14 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 121.473 -0.767 . . . . 0.0 111.362 166.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.9 mtp -69.38 -12.09 61.36 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.2 -40.04 0.44 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -173.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -75.45 -28.3 59.26 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.59 0.632 . . . . 0.0 111.627 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.77 -49.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.249 1.419 . . . . 0.0 111.316 -174.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 23.4 m0 -46.79 -61.32 2.83 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.37 -54.84 4.0 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 C-N-CA 123.319 2.68 . . . . 0.0 115.338 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.96 -37.5 26.3 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 CA-C-N 121.922 1.722 . . . . 0.0 113.007 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 36.0 tp -54.35 -48.07 71.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.576 0.75 . . . . 0.0 111.484 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.0 ttt -59.25 -50.48 73.83 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.547 1.139 . . . . 0.0 111.403 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.1 -35.25 73.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.327 1.051 . . . . 0.0 113.119 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.47 -58.27 4.57 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.013 1.325 . . . . 0.0 112.156 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 95.3 mt -64.25 -56.23 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 124.551 1.14 . . . . 0.0 111.08 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GMA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_